Processing 00000000.tx.1: Amyloid -Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor* Matthew L. 

Phrase: "Amyloid -Protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Is"

Phrase: "Degraded by Cellular Angiotensin-converting Enzyme (ACE)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0007634:Cellular [Cell]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0178539:Cellular [Functional Concept]
   753   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "and"

Phrase: "Elevated by an ACE Inhibitor"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C0003015:Angiotensin-converting enzyme inhibitor [Pharmacologic Substance]
   853   C2757044:Angiotensin Converting Enzyme Inhibitor [Molecular Function]
   853   C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   814   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   778   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   778   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   774   C0743534:elevated enzyme [Finding]
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0205250:Elevated [Qualitative Concept]
   748   C1999216:Inhibitor [Qualitative Concept]
   748   C3163633:Elevated [Qualitative Concept]

Phrase: "* Matthew L."
Processing 00000000.tx.2: Hemming and Dennis J. 

Phrase: "Hemming"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0019080:HEM [Pathologic Function]
   966   C0280599:HEM [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Dennis J."
Processing 00000000.tx.3: Selkoe1 From the Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115 Received for publication, August 2, 2005 , and in revised form, September 8, 2005.  

Phrase: "Selkoe1 From the Center"

Phrase: "for Neurologic Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0027765:Neurologic Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "Brigham and Women's Hospital"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0043210:Women [Population Group]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "and"

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 02115"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024874:Massachusetts [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "August 2,"

Phrase: "2005 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "September 8,"

Phrase: "2005."
Processing 00000000.tx.4: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Human genetic data have associated angiotensin-converting enzyme (ACE) with Alzheimer disease (AD), and purified ACE has been reported to cleave synthetic amyloid -protein (A) in vitro. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Human genetic data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0596723:human data [Intellectual Product,Research Activity]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   706   C0086418:Human - origin [Human]

Phrase: "have"

Phrase: "associated angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "with Alzheimer disease (AD),"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "purified ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "synthetic amyloid -protein (A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   861   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.5: Whether deficiency in ACE activity, arising from genetic alteration or pharmacological inhibition, can decrease A degradation and allow A accumulation in intact cells is unknown. 

Phrase: "Whether"

Phrase: "deficiency in ACE activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0149676:Enzyme Deficiency [Disease or Syndrome]
   753   C0011155:Deficiency [Functional Concept]
   753   C0162429:Deficiency [Disease or Syndrome]
   753   C1623416:deficiency [Qualitative Concept]
   716   C2258685:angiotensin converting enzyme activity [Molecular Function]

Phrase: "arising from genetic alteration"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   833   C0026882:Genetic Alteration [Genetic Function]
   833   C1704257:Genetic Alteration [Finding]
   833   C1705285:Genetic Alteration [Cell or Molecular Dysfunction]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C0332284:arising [Qualitative Concept]
   770   C1515926:Alteration [Idea or Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "or"

Phrase: "pharmacological inhibition,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "can"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "A degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "A accumulation in intact cells"

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.6: We cloned ACE from human neuroblastoma cells and showed that it had posttranslational processing and enzymatic activity typical of the endogenous protease. 

Phrase: "We"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "ACE from human neuroblastoma cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "it"

Phrase: "had"

Phrase: "posttranslational processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "enzymatic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2267219:Enzymatic Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "typical of the endogenous protease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3538928:Typical [Qualitative Concept]
Processing 00000000.tx.7: Cellular expression of ACE promoted degradation of naturally secreted A40 and A42, leading to significant clearance of both species. 

Phrase: "Cellular expression of ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "degradation of naturally secreted A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "A42,"

Phrase: "leading to significant clearance of both species."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   748   C0237881:significant [Quantitative Concept]
   748   C0332152:Leading [Temporal Concept]
   748   C0449297:Clearance [Qualitative Concept]
   748   C0750502:Significant [Idea or Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C1522538:Leading [Functional Concept]
   748   C1546944:Significant [Qualitative Concept]
   748   C1705920:Species [Conceptual Entity]
   748   C2825073:Clearance [Natural Phenomenon or Process]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.8: Using site-directed mutagenesis, we determined that both active sites within ACE contribute to A clearance, and an ACE construct bearing mutations in each catalytic domain had no effect on A levels. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "site-directed mutagenesis,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "we"

Phrase: "determined"

Phrase: "that"

Phrase: "both active sites within ACE"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C0205681:Sites, Active [Functional Concept]
   748   C0205145:Sites [Spatial Concept]
   748   C0205177:Active [Functional Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "contribute to A clearance,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C1880177:Contribute [Activity]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "an ACE construct bearing mutations in each catalytic domain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0026882:Mutations [Genetic Function]
   704 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "had"

Phrase: "no effect on A levels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.9: Pharmacological inhibition of ACE with a widely prescribed drug, captopril, promoted the accumulation of cell-derived A in the media of -amyloid precursor-protein expressing cells. 

Phrase: "Pharmacological inhibition of ACE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0877008:enzyme inhibition [Disease or Syndrome]
   783   C1524081:Enzyme Inhibition [Physiologic Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "with a widely prescribed drug,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0013227:Drug [Pharmacologic Substance]
   827   C1254351:Drug [Pharmacologic Substance]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "captopril,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the accumulation of cell-"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "A in the media of -amyloid precursor-protein expressing cells."
Meta Candidates (Total=25; Excluded=6; Pruned=0; Remaining=19)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   775   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Amyloid A
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0018956:cells precursor [Cell]
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0007634:Cells [Cell]
   739   C0009458:Media [Intellectual Product]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0162867:Media [Tissue]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1254021:Media [Tissue]
   739   C1709634:Precursor [Idea or Concept]
   739   C3282337:Cells [Cell]
   706 E C0439536:Medium [Quantitative Concept]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1705217:Medium [Substance]
   706 E C1948049:Cell [Spatial Concept]
   706 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.10: Together, these results show that ACE can lower the levels of secreted A in living cells and that this effect is blocked by inhibiting the protease's activity with an ACE inhibitor. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "can"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "the levels of secreted A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in living cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "blocked by inhibiting"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   790   C3463820:Inhibiting [Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "the protease's activity with an ACE inhibitor."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   838   C1152583:angiotensin-converting enzyme inhibitor activity [Molecular Function]
   810   C2258685:angiotensin converting enzyme activity [Molecular Function]
   784   C1152555:enzyme inhibitor activity [Molecular Function]
   781   C1152582:protease inhibitor activity [Molecular Function]
   764   C1150095:protease activity [Molecular Function]
   762   C0243102:enzyme activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.11: This work, combined with the genetic studies, supports the hypothesis that ACE may modulate the susceptibility to and progression of AD via degradation of A. 

Phrase: "This work,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "combined with the genetic studies,"
Meta Candidates (Total=15; Excluded=10; Pruned=0; Remaining=5)
   790   C2827447:Genetic Study [Research Activity]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0205195:Combined [Qualitative Concept]
   760   C0314603:Genetic [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0336789:Combine [Manufactured Object]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the susceptibility to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0012655:Susceptibility [Clinical Attribute]
   790   C0220898:Susceptibility [Organism Attribute]
   790   C1264642:Susceptibility [Functional Concept]
   790   C1547045:*Susceptibility [Quantitative Concept]
   718 E C0231204:Susceptible [Functional Concept]
   718 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "and"

Phrase: "progression of AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0242656:Disease Progression [Pathologic Function]
           progression
   819   C1947900:Disease progression NOS [Finding]
   770   C0449258:Progression [Functional Concept]

Phrase: "via degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "of A."
Processing 00000000.tx.12: Our data encourage further analyses of the ACE gene for disease association and raise the question of whether currently prescribed ACE inhibitors could elevate cerebral A levels in humans.  

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "encourage"

Phrase: "further analyses of the ACE gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]

Phrase: "for disease association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1511978:Disease Association [Temporal Concept]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "raise"

Phrase: "the question of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "currently prescribed ACE inhibitors"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   901   C0003015:Angiotensin-Converting Enzyme Inhibitors [Pharmacologic Substance]
   901   C2757044:Angiotensin-converting Enzyme Inhibitors [Molecular Function]
   867 E C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   861   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   827   C1152555:enzyme inhibitors [Molecular Function]
   827   C2756995:Enzyme Inhibitors [Molecular Function]
   799   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   766 E C1999216:Inhibitor [Qualitative Concept]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "could"

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "cerebral"

Phrase: "A levels in humans."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  An early and pathogenically important feature of Alzheimer disease (AD)2 is the progressive accumulation and deposition of the amyloid -protein (A) in brain regions serving memory and cognition. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "An early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "pathogenically important feature of Alzheimer disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "(AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "is"

Phrase: "the progressive accumulation"

Phrase: "and"

Phrase: "deposition of the amyloid -protein (A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0011560:Amyloid deposition [Pathologic Function]
   783   C0333584:Protein deposition [Pathologic Function]
   783   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]

Phrase: ")"

Phrase: "in brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "serving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519269:Serving [Quantitative Concept]

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "cognition."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]
Processing 00000000.tx.14: Biochemical, cell biological, animal modeling, genetic, and emerging clinical data all suggest that A is an upstream initiator of the disease process and its associated neuropathology (1-4). 

Phrase: "Biochemical, cell biological, animal modeling,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0870071:Modeling [Intellectual Product,Research Activity]

Phrase: "genetic,"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "emerging clinical data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1516606:Clinical Data [Intellectual Product]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "all"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "A"

Phrase: "is"

Phrase: "an upstream initiator of the disease process"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1444748:Initiator [Qualitative Concept]

Phrase: "and"

Phrase: "its associated neuropathology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   861   C1540677:neuropathology [Pathologic Function]
   861   C1555824:Neuropathology [Intellectual Product]

Phrase: "(1-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Although no proven disease-modifying treatments are currently available, recent efforts to treat AD have focused on both decreasing the production of A and enhancing its clearance from the brain. 

Phrase: "Although"

Phrase: "no proven disease-modifying treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0087111:Treatments [Therapeutic or Preventive Procedure]
   779 E C0039798:treatment [Functional Concept]
   779 E C1522326:Treatment [Functional Concept]
   779 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   779 E C1705169:Treatment [Conceptual Entity]
   779 E C3538994:TREATMENT [Research Activity]

Phrase: "are"

Phrase: "currently available, recent efforts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0015264:Effort [Organism Function]

Phrase: "treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "focused on both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205234:Focused [Spatial Concept]
   790   C1285542:focused [Functional Concept]

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the production of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "its clearance from the brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.16: One little studied approach to A clearance is augmenting the degradation of the peptide by various proteases expressed in the brain. 

Phrase: "One little studied approach to A clearance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449445:Approach [Spatial Concept]

Phrase: "is"

Phrase: "augmenting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205217:augment [Quantitative Concept]

Phrase: "the degradation of the peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1523817:peptide degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "by various proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "expressed in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.17: Thus far, the metalloproteases neprilysin (NEP) (5), insulin-degrading enzyme (IDE) (6), and the endothelin-converting enzymes 1 and 2 (7) have each been implicated as A-degrading proteases in the mammalian brain. 

Phrase: "Thus far,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "the metalloproteases neprilysin (NEP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "insulin-degrading enzyme (IDE)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the endothelin-converting enzymes 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   983   C0246118:Endothelin-converting enzyme 1 [Amino Acid, Peptide, or Protein,Enzyme]
   983   C1414244:ENDOTHELIN-CONVERTING ENZYME 1 [Gene or Genome]
   902   C0079281:Endothelin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1414260:ENDOTHELIN 1 [Gene or Genome]
   890   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]
   812   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(7"

Phrase: ")"

Phrase: "have"

Phrase: "each"

Phrase: "been"

Phrase: "implicated as A-degrading proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1947941:Proteases [Enzyme]

Phrase: "in the mammalian brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.18: The serine protease plasmin has been implicated in A degradation in vitro (8), although genetic plasmin deficiency did not promote accumulation of murine A in vivo (9). 

Phrase: "The serine protease plasmin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   734   C0036734:serine protease [Amino Acid, Peptide, or Protein,Enzyme]
   734   C2717971:Serine Protease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in A degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "genetic plasmin deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "accumulation of murine"

Phrase: "A in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.19: Supporting a role for therapeutic regulation of A-degrading proteases, the overexpression of IDE or NEP in a murine model of AD decreased cerebral A levels and produced significant attenuation of A-associated neuropathology (10). 

Phrase: "Supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a role for therapeutic regulation of A-degrading proteases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "the overexpression of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "or"

Phrase: "NEP in a murine model of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "cerebral"

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "produced significant attenuation of A-associated neuropathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0599946:Attenuation [Activity]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.20: Somatic angiotensin-converting enzyme (ACE) is a zinc metalloprotease containing two homologous regions, termed the N- and C-domains, each of which is proteolytically active (11). 

Phrase: "Somatic angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "is"

Phrase: "a zinc metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "two homologous regions,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C1334043:Homologous [Gene or Genome]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "each of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "is"

Phrase: "proteolytically active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.21: ACE has a single transmembrane domain and is cleaved from the cell surface at a low rate, resulting in the secretion of its ectodomain into the media of cultured cells and plasma (12, 13). 

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "a single transmembrane domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1519623:Transmembrane Domain [Amino Acid Sequence]
   827   C1167322:transmembrane [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C2752508:transmembrane [Cell Component]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "is"

Phrase: "cleaved from the cell surface"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0699040:Cell surface [Cell Component]
   797   C0333853:Cleaved cell [Cell]
           Cleaved
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0205242:Cleaved [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "at a low rate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "resulting in the secretion of its ectodomain"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   778   C0332294:Resulting in [Functional Concept]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0678226:resulting [Functional Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "into the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "of cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.22: ACE has been intensively characterized for its role in the regulation of blood pressure by cleaving angiotensin I to angiotensin II and inactivating bradykinin (14). 

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "intensively"

Phrase: "characterized for its role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
   770   C1880022:Characterized [Activity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0005823:Blood Pressure [Organism Function]
  1000   C1271104:Blood Pressure [Finding]
  1000   C1272641:Blood pressure [Finding]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0229664:Blood [Body Substance]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "by cleaving angiotensin I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021107:Insertion [Therapeutic or Preventive Procedure]
   827   C0441587:Insertion [Health Care Activity]
   827   C1512796:Insertion [Genetic Function]
   827   C1883719:Insertion [Functional Concept]

Phrase: "to angiotensin II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "inactivating bradykinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1537501:bradykinin [Gene or Genome]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.23: This function of ACE is modulated pharmacologically by ACE inhibitors, which bind competitively to the active site zinc to prevent substrate hydrolysis. 

Phrase: "This function of ACE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "modulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulated [Spatial Concept]

Phrase: "pharmacologically by ACE inhibitors,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   882   C0003015:Angiotensin-Converting Enzyme Inhibitors [Pharmacologic Substance]
   882   C2757044:Angiotensin-converting Enzyme Inhibitors [Molecular Function]
   849 E C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   833   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   790   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   790   C1152555:enzyme inhibitors [Molecular Function]
   790   C2756995:Enzyme Inhibitors [Molecular Function]
   756 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "competitively to the active site zinc to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0205681:Active Site [Functional Concept]
   748   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0205145:Site [Spatial Concept]
   748   C0205177:Active [Functional Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2348288:Zinc [Element, Ion, or Isotope]
   748   C2825164:Site [Spatial Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "substrate hydrolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]
Processing 00000000.tx.24: This commonly prescribed class of drugs is used for the treatment of hypertension and other disorders. 

Phrase: "This commonly prescribed class of drugs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456387:Class [Intellectual Product]
   753   C1705943:Class [Classification]

Phrase: "is"

Phrase: "used for the treatment of hypertension"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   783   C0578998:hypertension treatment [Health Care Activity]
   767   C1524063:Use of [Functional Concept]
   753   C0020538:Hypertension [Disease or Syndrome]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1273517:used [Finding]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C1963138:Hypertension [Finding]
   753   C3538994:TREATMENT [Research Activity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "other disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.25: In addition to regulating vasoactive peptides, ACE shows a broad substrate specificity, including several neuropeptides, and it is able to metabolize substrates using both exopeptidase and endopeptidase activities (15). 

Phrase: "In addition to"

Phrase: "regulating"

Phrase: "vasoactive peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a broad substrate specificity,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0038592:Substrate Specificity [Quantitative Concept]
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   827   C1710236:Substrate [Manufactured Object]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "several neuropeptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "metabolize"

Phrase: "substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both exopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0117059:Exopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "endopeptidase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1150171:endopeptidase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.26: Interestingly, despite their homology, the N- and C-domains display differential capacity to degrade some substrates and can be inhibited selectively by certain ACE inhibitors (16, 17). 

Phrase: "Interestingly,"

Phrase: "despite their homology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334043:Homology [Gene or Genome]
  1000   C2697616:Homology [Qualitative Concept]

Phrase: "the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "differential capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "degrade"

Phrase: "some substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "selectively by certain ACE inhibitors"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   853   C0003015:Angiotensin-Converting Enzyme Inhibitors [Pharmacologic Substance]
   853   C2757044:Angiotensin-converting Enzyme Inhibitors [Molecular Function]
   820 E C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   814   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   778   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   778   C1152555:enzyme inhibitors [Molecular Function]
   778   C2756995:Enzyme Inhibitors [Molecular Function]
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   745 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.27: Recently, ACE was found to participate in the c-Jun N-terminal kinase signal transduction pathway, apparently independently of its proteolytic function (18). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate in the c-Jun N-terminal kinase signal transduction pathway,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   797   C1367731:JUN N-terminal kinase [Gene or Genome]
   775   C0086982:Signal Transduction Pathway [Molecular Function]
   756   C0037083:Signal Transduction [Cell Function]
   754   C0037080:Signal Pathway [Molecular Function]
   754   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   754   C1334482:Jun kinase [Gene or Genome]
   754   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205088:Terminal [Temporal Concept]
   738   C1160185:transduction [Organism Function]
   738   C1704259:Pathway [Molecular Function]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C1705987:Pathway [Conceptual Entity]
   738   C1710082:Signal [Phenomenon or Process]
   738   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "apparently independently of its proteolytic function"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0597304:Proteolytic [Molecular Function]
   753   C0700205:FUNCTION [Classification]
   753   C0750541:apparently [Idea or Concept]
   753   C1705273:Function [Intellectual Product]
   753   C1947941:proteolytic [Enzyme]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.28: A potential relationship between ACE and AD was first suggested by human genetic studies, which reported that an insertion (I)/deletion (D) polymorphism within intron 16 of the ACE gene associates with AD (19). 

Phrase: "A potential relationship between ACE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "suggested by human genetic studies,"
Meta Candidates (Total=17; Excluded=9; Pruned=0; Remaining=8)
   797   C0178693:human studies [Research Activity]
   790   C2827447:Genetic Study [Research Activity]
   778   C0086418:Human - origin [Human]
           Human
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726   C1705535:Suggest [Idea or Concept]
   726 E C2603343:Study [Research Activity]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "which"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "an insertion (I)/deletion (D) polymorphism within intron 16"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0021107:Insertion [Therapeutic or Preventive Procedure]
   748   C0032529:Polymorphism [Genetic Function]
   748   C0441587:Insertion [Health Care Activity]
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1512796:Insertion [Genetic Function]
   748   C1880274:Deletion [Activity]
   748   C1882417:Polymorphism [Qualitative Concept]
   748   C1883719:Insertion [Functional Concept]

Phrase: "of the ACE gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333402:Enzyme Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "associates with AD"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.29: Specifically, the I allele was associated with an increased risk for AD, whereas the D allele was associated with protection (20, 21). 

Phrase: "Specifically,"

Phrase: "the I allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "associated with an increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "whereas"

Phrase: "the D allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "associated with protection"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1545588:Protection [Finding]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.30: Of potential mechanistic relevance, inheritance of the D allele has been associated with increased plasma ACE levels (22). 

Phrase: "Of potential mechanistic relevance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347946:Relevance [Qualitative Concept]

Phrase: "inheritance of the D allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242538:Inheritance [Quantitative Concept]
   760   C0728826:Inheritance [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "associated with increased plasma ACE levels"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   800   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   770   C0014440:enzyme levels [Laboratory Procedure]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1287349:enzyme levels [Laboratory or Test Result]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0032105:Plasma [Body Substance]
   744   C0205217:Increased [Quantitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   711 E C0456079:Level [Classification]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1547707:Level [Geographic Area]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.31: Regarding disease specificity, the I allele has been found to associate positively with AD but not with vascular dementia or vascular pathology (23, 24). 

Phrase: "Regarding disease specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "the I allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "associate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "positively with AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "but"

Phrase: "not with vascular dementia"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0011269:Dementia, Vascular [Disease or Syndrome]
   770   C0005847:vascular [Body Part, Organ, or Organ Component]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
   770   C1518422:Not [Functional Concept]
   770   C1558950:VASCULAR [Finding]
   770   C1801960:Vascular [Qualitative Concept]
   715 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   715 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "or"

Phrase: "vascular pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.32: The I/I genotype has also been linked to smaller volumes of the hippocampus and the amygdala (24). 

Phrase: "The I/I genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "linked to smaller volumes of the hippocampus"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   748   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   748   C0449468:volumes [Quantitative Concept]
   748   C0547044:Smaller [Qualitative Concept]
   748   C0700321:Smaller [Quantitative Concept]
   748   C0949582:Hippocampus [Fish]
   748   C1029104:Hippocampus [Fish]
   748   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   714   C1517892:Link [Intellectual Product]
   714 E C1690016:% volume [Qualitative Concept]
   714   C1704666:Link [Intellectual Product]
   714 E C1705102:Volume [Intellectual Product]
   714 E C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "the amygdala"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.33: Importantly, post-mortem analyses of AD patients determined that those with the I/I genotype had a trend toward increased brain A42 load compared with the D/D genotype (25). 

Phrase: "Importantly,"

Phrase: "post-mortem analyses of AD patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "determined"

Phrase: "that"

Phrase: "those with the I/I genotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017431:Genotype [Organism Attribute]
   753   C0021107:Insertion [Therapeutic or Preventive Procedure]
   753   C0441587:Insertion [Health Care Activity]
   753   C1512796:Insertion [Genetic Function]
   753   C1883719:Insertion [Functional Concept]

Phrase: "had"

Phrase: "a trend toward increased brain A42 load"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521798:trend [Temporal Concept]

Phrase: "compared with the D/D genotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017431:Genotype [Organism Attribute]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1707455:Compared [Activity]
   753   C1880274:Deletion [Activity]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.34: Single nucleotide polymorphisms in the ACE gene have also been shown to associate with AD, and there is a decrease in the prevalence of the AD-susceptible genotype with increased age, consistent with a modulation of longevity (26). 

Phrase: "Single nucleotide polymorphisms in the ACE gene"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   762   C0678951:gene polymorphisms [Genetic Function]
   742   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0032529:polymorphisms [Genetic Function]
   742   C0037179:Single [Population Group]
   742   C0087136:single [Finding]
   742   C0205171:Single [Quantitative Concept]
   708 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "associate with AD,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "there"

Phrase: "is"

Phrase: "a decrease in the prevalence of the AD-susceptible genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392756:Decrease [Qualitative Concept]
   738   C0547047:Decrease [Quantitative Concept]

Phrase: "with increased age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "consistent with a modulation of longevity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.35: Post-mortem studies of patients with AD have found elevated levels of ACE in the temporal cortex and specifically within pyramidal cortical neurons (27, 28) as well as significantly increased ACE activity in the medial hippocampus, parahippocampal gyrus, frontal cortex, and caudate nucleus (29). 

Phrase: "Post-mortem"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0004398:postmortem [Diagnostic Procedure]
  1000   C0580205:Postmortem [Temporal Concept]
  1000   C0848632:post mortem [Finding]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "studies of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]

Phrase: "with AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "elevated levels of ACE"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0014440:enzyme levels [Laboratory Procedure]
   783   C1287349:enzyme levels [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the temporal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "specifically within pyramidal cortical neurons"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0027882:Neurons [Cell]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "(27,"

Phrase: "28"

Phrase: ")"

Phrase: "as well as"

Phrase: "significantly increased ACE activity in the medial hippocampus,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C2258685:angiotensin converting enzyme activity [Molecular Function]
   782   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   760   C0243102:enzyme activity [Molecular Function]
   757   C0474395:increased activity [Finding]
   739   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "parahippocampal gyrus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0228249:Parahippocampal Gyrus [Body Part, Organ, or Organ Component]
  1000   C1284606:Parahippocampal gyrus [Body Part, Organ, or Organ Component]

Phrase: "frontal cortex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "caudate nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007461:Caudate Nucleus [Body Part, Organ, or Organ Component]
  1000   C1269580:Caudate nucleus [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.36: A mechanistic link between ACE and AD was suggested when affinity-purified ACE was shown to degrade synthetic A-(1-40) between the Asp7-Ser8 bond in vitro, producing a truncated 33-residue peptide that exhibited decreased aggregation and cytotoxic potential (30). 

Phrase: "A mechanistic link between ACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "when"

Phrase: "affinity-purified ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "synthetic A-(1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439509:/40 [Temporal Concept]
   812   C1883254:synthetic [Activity]

Phrase: ")"

Phrase: "between the Asp7-Ser8"

Phrase: "bond"

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "producing"

Phrase: "a truncated 33-residue peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "that exhibited decreased aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "cytotoxic potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.37: A plausible interpretation of the above genetic, neuropathological, and biochemical findings is that ACE is implicated in AD via direct proteolysis of the A peptide, modulating A levels within the brain. 

Phrase: "A plausible interpretation of the above genetic, neuropathological,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0459471:Interpretation [Intellectual Product]
   744   C3173575:Interpretation [Clinical Attribute]

Phrase: "and"

Phrase: "biochemical findings"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C0428132:Biochemical finding [Laboratory or Test Result]
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "is"

Phrase: "that ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "implicated in AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "via direct proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597304:Proteolysis [Molecular Function]
   789 E C1947941:proteolytic [Enzyme]

Phrase: "of the"

Phrase: "A peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "A levels within the brain."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.38: This hypothesis suggests that reduced ACE activity, either by genetic mechanisms or chronic pharmacological inhibition, could increase cerebral levels of A40 and/or A42 and thus presumably increase the risk of developing AD and/or contribute to its progression. 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that reduced ACE activity,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   937   C2258685:angiotensin converting enzyme activity [Molecular Function]
   897   C0086439:Reduced Activity [Sign or Symptom]
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   840   C0243102:enzyme activity [Molecular Function]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "either by genetic mechanisms"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "or"

Phrase: "chronic pharmacological inhibition,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "could"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "cerebral levels of A40"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and/or"

Phrase: "A42"

Phrase: "and"

Phrase: "thus presumably"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of developing AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]

Phrase: "and/or"

Phrase: "contribute to its progression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.39: To address this hypothesis in intact, living cells, we cloned and characterized human neural ACE and determined its role in the clearance of secreted A.We demonstrate that ACE promotes the clearance of naturally produced A40 and A42 and leads to secondary degradation of both A species. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this hypothesis in intact,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512571:Hypothesis [Idea or Concept]

Phrase: "living"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0376558:Living [Idea or Concept]
   966 E C1548795:Live [Qualitative Concept]
   966 E C1634625:% live [Qualitative Concept]
   966 E C2982691:Live [Activity]

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "characterized human neural ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   799   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "determined"

Phrase: "its role in the clearance of secreted A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "We"

Phrase: "demonstrate"

Phrase: "that ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the clearance of naturally produced A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "A42"

Phrase: "and"

Phrase: "leads to secondary degradation of both"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   783   C0175668:Secondary to [Temporal Concept]
           Secondary
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0027627:secondary [Neoplastic Process]
   753   C0181586:leads [Medical Device]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "A species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.40: Further, by using site-directed mutagenesis in the context of the full-length enzyme, we show that both the N- and C-domains of ACE are capable of promoting A degradation with similar capacity. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "site-directed mutagenesis in the context of the full-length enzyme,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   775   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   754   C2945843:Site of [Qualitative Concept]
   738   C0079866:Mutagenesis [Molecular Function]
   738   C0205145:Site [Spatial Concept]
   738   C1515974:Site [Body Location or Region]
   738   C2825164:Site [Spatial Concept]
   738   C3146302:Mutagenesis [Laboratory Procedure]
   704   C0439851:Direct [Qualitative Concept]
   704   C1947931:Direct [Qualitative Concept]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-domains of ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "capable of promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "A degradation with similar capacity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.41: Finally, we demonstrate that treatment of A-secreting cells with a commonly prescribed ACE inhibitor prevents ACE-mediated A clearance and results in accumulation of the A peptide.  

Phrase: "Finally,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that treatment of A-secreting cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with a commonly prescribed ACE inhibitor"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0003015:Angiotensin-converting enzyme inhibitor [Pharmacologic Substance]
   901   C2757044:Angiotensin Converting Enzyme Inhibitor [Molecular Function]
   901   C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   861   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   827   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   799   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C1999216:Inhibitor [Qualitative Concept]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "ACE-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "A clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "results in accumulation of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "A peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.42: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Cloning of ACE and Creation of Active Site MutantsThe 4.0-kb ACE cDNA was obtained by reverse transcription-PCR of RNA isolated from the human neuroblastoma cell line SK-N-SH. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Cloning of ACE"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   862   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   760   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0009015:Cloning [Research Activity]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   726 E C0009013:Clone [Cell]
   726 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "Creation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441513:Creation [Therapeutic or Preventive Procedure]
  1000   C1706214:Creation [Activity]

Phrase: "of Active Site MutantsThe 4.0-kb ACE cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "obtained by reverse transcription-PCR of RNA"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0035380:Reverse Transcription [Genetic Function]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0040649:Transcription [Genetic Function]
   748   C0677874:pCR [Finding]
   748   C1301820:Obtained [Functional Concept]
   748   C1555029:Reverse [Idea or Concept]
   714 E C1706701:Obtain [Activity]

Phrase: "isolated from the human neuroblastoma cell line SK-N-SH."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   777   C0682523:Human Cell Line [Cell]
   760   C0007600:Cell Line [Cell]
   760   C0815000:neuroblastoma cell [Cell]
   757   C0427861:cell human [Laboratory or Test Result]
   739   C0007634:Cell [Cell]
   739   C0027819:Neuroblastoma [Neoplastic Process]
   739   C0038108:SH [Geographic Area]
   739   C0086418:Human [Human]
   739   C0205132:Line [Spatial Concept]
   739   C0205409:Isolated [Functional Concept]
   739   C0700095:neuroblastoma [Neoplastic Process]
   739   C1269647:Cell [Cell]
   739   C1548221:Isolated [Idea or Concept]
   739   C1550648:Line [Substance]
   739   C1552960:Line [Quantitative Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   739   C3540583:Neuroblastoma [Intellectual Product]
   706 E C0370215:Isolate [Substance]
   706 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.43: 5'- and 3'-end primers used to amplify the sequence were (5'-GGAAGCTTGCCGAGCACCGCGCACCGC-3') and (5'-CAGTGTTCCCATCCCAGTCT-3'), respectively. 

Phrase: "5'-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3'-end primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "amplify"

Phrase: "the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "(5'-GGAAGCTTGCCGAGCACCGCGCACCGC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and ("

Phrase: "5'-CAGTGTTCCCATCCCAGTCT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.44: This coding region contains the full-length ACE protein, including signal peptide, N- and C-catalytic domains, transmembrane domain, and the cytoplasmic C terminus (Fig. 1B). 

Phrase: "This coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the full-length ACE protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "signal peptide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037081:Signal Peptide [Amino Acid Sequence]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-catalytic domains,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0600499:Domains, Catalytic [Amino Acid Sequence]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "transmembrane domain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C2752508:transmembrane [Cell Component]
   861   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the cytoplasmic C terminus"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.45: The neurally derived ACE cDNA was cloned into the pcDNA5/FRT expression vector and confirmed by DNA sequencing to be identical to the reported human ACE cDNA sequence. 

Phrase: "The neurally derived ACE cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "cloned into the pcDNA5/FRT expression vector"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0009013:cloned [Cell]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]
   748   C1705150:FRT [Gene or Genome]
   714 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "confirmed by DNA sequencing to"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0162326:DNA sequencing [Nucleotide Sequence]
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   806   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "be"

Phrase: "identical to the reported human ACE cDNA sequence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.46: The full-length ACE cDNA was used as the template for oligonucleotide-directed mutagenesis with the QuikChange XL site-directed mutagenesis kit (Stratagene) to generate the catalytically inactive ACE constructs. 

Phrase: "The full-length ACE cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as the template"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0728990:TEMPLATE [Medical Device]
   770   C1273517:used [Finding]
   770   C1514575:Template [Conceptual Entity]
   770   C1705542:Template [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "for oligonucleotide-directed mutagenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079869:Oligonucleotide-Directed Mutagenesis [Molecular Biology Research Technique]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "with the QuikChange XL site-directed mutagenesis kit (Stratagene"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "the catalytically inactive ACE constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C2827421:Construct [Classification]
Processing 00000000.tx.47: The two ACE zinc metalloprotease active site glutamates (amino acids 362 in the C-domain and 960 in the N-domain) were changed to aspartates using the following primers: for E362D, 5'-CCACAGTGCACCATGACATGGGCCATATACAG-3' (forward) and 5'-ACTGTATATGGCCCATGTCATGGTGCACTGTGG-3' (reverse); 

Phrase: "The two ACE zinc metalloprotease active site glutamates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   791   C0017789:Glutamates [Amino Acid, Peptide, or Protein]
   758 E C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(amino acids 362 in the C-domain"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "960 in the N-domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "changed to aspartates"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:Changed [Functional Concept]
   790   C0443172:Changed [Quantitative Concept]
   756   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "for E362D,"

Phrase: "5'-CCACAGTGCACCATGACATGGGCCATATACAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "5'-ACTGTATATGGCCCATGTCATGGTGCACTGTGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.48: for E960D, 5'-GGCCCACCACGACATGGGCCACATC-3' (forward) and 5'-GATGTGGCCCATGTCGTGGTGGGCC-3' (reverse). 

Phrase: "for E960D,"

Phrase: "5'-GGCCCACCACGACATGGGCCACATC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "5'-GATGTGGCCCATGTCGTGGTGGGCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.49: Mutant constructs were cloned into pcDNA5/FRT and screened by DNA sequencing to ensure that no other mutations had occurred. 

Phrase: "Mutant constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "cloned into pcDNA5/FRT"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0009013:cloned [Cell]
   770   C1705150:FRT [Gene or Genome]
   737 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "screened by DNA sequencing to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0162326:DNA sequencing [Nucleotide Sequence]
   806   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]
   726   C0220908:screen [Health Care Activity]
   726   C1305399:screen [Functional Concept]
   726   C1705053:Screen [Medical Device]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "no other mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "had"

Phrase: "occurred."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.50: Four constructs were thus generated: the N-domain mutant, the C-domain mutant, the combined N- and C-domain mutant, and the wild-type enzyme. 

Phrase: "Four constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "thus"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ":"

Phrase: "the N-domain mutant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
   734   C1513868:N Domain [Amino Acid Sequence]

Phrase: "the C-domain mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "the combined N-"

Phrase: "and"

Phrase: "C-domain mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "the wild-type enzyme."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.51: All expression plasmids were characterized by both restriction digestion and DNA sequencing of the entire ACE cDNA. 

Phrase: "All expression plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "characterized by both restriction digestion"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0012238:Digestion [Organism Function]
   760   C0443288:Restriction [Functional Concept]
   760   C1880022:Characterized [Activity]
   760   C2349986:Digestion [Research Activity]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "DNA sequencing of the entire ACE cDNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0162326:DNA sequencing [Nucleotide Sequence]
   764   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   742   C1553778:Sequencing [Intellectual Product]
   742   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.52: The HA-tagged IDE construct in the pcDNA5/FRT vector has been previously described (31). 

Phrase: "The HA-tagged IDE construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2827421:Construct [Classification]

Phrase: "in the pcDNA5/FRT vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.53: Cell CultureChinese hamster ovary (CHO) and human embryonic kidney 293 (HEK293) cells were grown in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 2 mM L-glutamine, 100 g/ml penicillin, and 100 g/ml streptomycin. 

Phrase: "Cell CultureChinese hamster ovary (CHO)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "human embryonic kidney 293 (HEK293) cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   897   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   836   C0553257:kidney cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "2 mM L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "100 g/ml penicillin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0030827:g penicillin [Antibiotic,Organic Chemical]
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "100 g/ml streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.54: HEK293 cells stably expressing APP695 bearing the K595N/M596L ("Swedish") AD-causing mutation (32) were selected in medium containing 200 g/ml G418. 

Phrase: "HEK293 cells stably"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   876   C0427861:Human cells [Laboratory or Test Result]
   841   C1947950:Embryonic Cell [Embryonic Structure]
   822   C0553257:kidney cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "APP695"

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the K595N/M596L"

Phrase: "(""Swedish"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710263:Swedish [Population Group]

Phrase: ")"

Phrase: "AD-causing mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C2985434:Disease-causing Mutation [Cell or Molecular Dysfunction]
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(32"

Phrase: ")"

Phrase: "were"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "in medium containing 200 g/ml G418."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0052009:G418 [Antibiotic,Organic Chemical]
Processing 00000000.tx.55: CHO cells stably transfected with APP751 with the V717F AD-causing mutation and a pFRT/lacZeo construct enabling Flp-InTM (Invitrogen) competence were grown in 200 g/ml G418 and 100 g/ml Zeocin. 

Phrase: "CHO cells stably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]

Phrase: "transfected with APP751"

Phrase: "with the V717F AD-causing mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C2985434:Disease-causing Mutation [Cell or Molecular Dysfunction]
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "a pFRT/lacZeo construct enabling Flp-InTM"

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "competence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086035:Competence [Qualitative Concept]

Phrase: "were"

Phrase: "grown in 200 g/ml G418"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0052009:G418 [Antibiotic,Organic Chemical]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "100 g/ml Zeocin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0537913:Zeocin [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.56: Once successful genomic recombination of pcDNA5/FRT constructs occurred, the Flp-In host cells lost Zeocin resistance and were selected with 350 g/ml hygromycin B. 

Phrase: "Once successful genomic recombination of pcDNA5/FRT constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0034865:Recombination [Genetic Function]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "the Flp-In host cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C1819995:Host Cell [Cell Component]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "Zeocin resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "were"

Phrase: "selected with 350 g/ml hygromycin B."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0020406:Hygromycin B [Carbohydrate,Pharmacologic Substance]
   778   C1300565:g/mL [Quantitative Concept]
   774 E C1637390:mL/g [Quantitative Concept]
   748   C0063201:hygromycin [Organic Chemical]
   748   C0439267:g% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   714   C1707391:Select [Activity]
Processing 00000000.tx.57: Effects of Capoten (captopril; Sigma) were assayed by a 24-h preincubation of cells with the drug, followed by an 18-h conditioning period in which cells were grown in serum-free Dulbecco's modified Eagle's medium (Invitrogen) with captopril. 

Phrase: "Effects of Capoten"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "(captopril"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "assayed by a 24-h preincubation of cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   744   C0007634:Cells [Cell]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
   744   C3282337:Cells [Cell]
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711 E C1269647:Cell [Cell]
   711   C1510438:Assay [Laboratory Procedure]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "with the drug,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "followed by an 18-h conditioning period"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0009647:Conditioning [Mental Process]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439531:/period [Temporal Concept]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C1948053:Period [Temporal Concept]
   714 E C0012634:condition [Disease or Syndrome]
   714 E C0348080:Condition [Qualitative Concept]
   714 E C1705253:Condition [Conceptual Entity]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "in which cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in serum-free Dulbecco's modified Eagle's medium"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   744   C0009458:Medium [Intellectual Product]
   744   C0229671:Serum [Body Substance]
   744   C0325564:Eagle [Bird]
   744   C0332296:free [Functional Concept]
   744   C0392747:Modified [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   744   C1551720:Eagle [Population Group]
   744   C1705217:Medium [Substance]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
   744   C3244283:medium [Intellectual Product]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "with captopril."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.58: Expression of Cloned Constructs in CHO and HEK293 CellsTransient transfections in CHO and HEK293 cell lines were performed using GenePorter 2 (GTS), and expression was assayed 24-42 h posttransfection. 

Phrase: "Expression of Cloned Constructs in CHO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "HEK293 CellsTransient transfections in CHO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C0029939:Ovary [Body Part, Organ, or Organ Component]
   788   C0227898:ovary [Body Part, Organ, or Organ Component]
   788   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "HEK293 cell lines"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   887   C0682523:Human Cell Line [Cell]
   876   C0427861:human cell [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   839   C0553257:kidney cell [Cell]
   827   C0007600:Cell lines [Cell]
   799   C0007634:Cell [Cell]
   799   C0205132:lines [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GenePorter 2"

Phrase: "(GTS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040517:GTS [Disease or Syndrome]
  1000   C1415353:GTS [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "24-42 h posttransfection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.59: CHO cell lines stably expressing APP751 with the V717F mutation and either empty vector, ACE, or mutant ACE constructs were generated using the Flp-InTM system (Invitrogen). 

Phrase: "CHO cell lines stably"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   877   C0007600:Cell lines [Cell]
   795   C0205132:lines [Spatial Concept]
   762 E C1550648:Line [Substance]
   762 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "APP751 with the V717F mutation"

Phrase: "and"

Phrase: "either empty vector,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "ACE,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "or"

Phrase: "mutant ACE constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C2827421:Construct [Classification]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Flp-InTM system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.60: This allowed stable integration of each construct into the same genomic locus of a single cell line. 

Phrase: "This allowed stable integration of each construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1158478:Integration [Genetic Function]
   748   C1705422:Integration [Machine Activity]

Phrase: "into the same genomic locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "of a single cell line."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.61: ImmunoblottingCells and tissue were lysed in 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Nonidet P-40, protease inhibitor mixture (Roche Applied Science), 2 mM 1,10-phenanthroline, and 5 mM EDTA, and the extracts were centrifuged at 1,000 x g for 10 min to remove nuclei. 

Phrase: "ImmunoblottingCells"

Phrase: "and"

Phrase: "tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "lysed in 50 mM Tris-HCl (pH 7.4"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C1882074:pH 7 [Qualitative Concept]
   762   C2678549:PH-4 [Gene or Genome]
   742   C0020283:[pH] [Quantitative Concept]
   742   C0024348:lysed [Pathologic Function]
   742   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0450407:ph+ [Finding]
   742   C0450408:ph++ [Finding]
   742   C0450409:ph+++ [Finding]
   742   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "protease inhibitor mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439962:Mixture [Substance]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "2 mM 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1418486:MM-1 [Gene or Genome]
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "and"

Phrase: "5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "at 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "000 x g for 10 min to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0560021:g/min [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "nuclei."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.62: Protein concentrations were determined using a bicinchoninic acid-based assay (Pierce). 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a bicinchoninic acid-based assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.63: Samples were then subject to SDS-PAGE and Western blotting. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then subject to SDS-PAGE"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1704732:Page [Intellectual Product]
   760   C1706203:Subject [Idea or Concept]
   760   C1883708:Then [Temporal Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.64: ACE was detected using a polyclonal antibody raised to amino acids 1-170 of human ACE (sc-20791; Santa Cruz Biotechnology, Inc.). 

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "raised to amino acids 1-170 of human ACE"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   775   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   756   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C0003006:Angiotensin 1 [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   738   C0001128:Acids [Chemical]
   738   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0086418:Human [Human]
   738   C0442818:Raised [Quantitative Concept]
   722 E C2917660:Amino Acid [Pharmacologic Substance]
   704 E C0202406:Acid [Laboratory Procedure]

Phrase: "(sc-20791"

Phrase: "; Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.65: Full-length human APP was detected using 8E5, reactive to APP-(444-592) of APP695 (gift of P. Seubert). 

Phrase: "Full-length human APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3538722:APP [Laboratory Procedure]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "8E5,"

Phrase: "reactive to APP-(444-592"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205332:Reactive [Qualitative Concept]

Phrase: ")"

Phrase: "of APP695"

Phrase: "(gift of P. Seubert"

Phrase: ")."
Processing 00000000.tx.66: APP C99 and C83 C-terminal fragments were detected using the polyclonal antibody C9, specific for residues 676-695 of APP695. 

Phrase: "APP C99"

Phrase: "and"

Phrase: "C83 C-terminal fragments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the polyclonal antibody C9,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1413029:C9 [Gene or Genome]
   827   C3540507:C9 [Gene or Genome]
   734   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "specific for residues 676-695 of APP695."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
Processing 00000000.tx.67: Total cellular IDE was detected using the polyclonal IDE-1 raised to amino acids 62-73 of human IDE (33). 

Phrase: "Total cellular IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the polyclonal IDE-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "raised to amino acids 62-73 of human IDE"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   775   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   775   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   756   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0001128:Acids [Chemical]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0086418:Human [Human]
   738   C0442818:Raised [Quantitative Concept]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
   722 E C2917660:Amino Acid [Pharmacologic Substance]
   704 E C0202406:Acid [Laboratory Procedure]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.68: HA-tagged IDE was detected using the anti-HA monoclonal 3F10 (Roche Applied Science). 

Phrase: "HA-tagged IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the anti-HA monoclonal 3F10"

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")."
Processing 00000000.tx.69: Deglycosylation was performed using peptide: N-glycosidase F to remove N-linked sugars and a mixture of the O-deglycosylating enzymes sialidase A, O-glycanase, (1-4)-galactosidase, and -N-acetylglucosaminidase (Prozyme). 

Phrase: "Deglycosylation"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "N-glycosidase F to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0377091:N-Glycosidase F [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "N-linked sugars"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0242209:Sugars [Carbohydrate,Pharmacologic Substance]
   793 E C0007004:Sugar [Carbohydrate]

Phrase: "and"

Phrase: "a mixture of the O-deglycosylating enzymes sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439962:Mixture [Substance]

Phrase: "A,"

Phrase: "O-glycanase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133487:O-glycanase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0061534:glycanase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "galactosidase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "N-acetylglucosaminidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699917:N acetylglucosaminidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001057:Acetylglucosaminidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Prozyme"

Phrase: ")."
Processing 00000000.tx.70: Western blots were probed with anti-mouse, anti-rat, or anti-rabbit secondary antibodies conjugated to Alexa Fluor 680 (Molecular Probes, Inc., Eugene, OR) or IRdye 800 (Rockland Immunochemicals). 

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "probed with anti-mouse, anti-rat,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "or"

Phrase: "anti-rabbit secondary antibodies"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0027627:secondary [Neoplastic Process]
   812   C0034493:Rabbit [Mammal]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "conjugated to Alexa Fluor 680"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C3272928:Alexa Fluor [Indicator, Reagent, or Diagnostic Aid]
   760   C0235665:FLUOR [Pathologic Function]
   760   C0522529:Conjugated [Spatial Concept]
   760   C1071616:Alexa [Plant]
   726 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Inc.,"

Phrase: "Eugene,"

Phrase: "OR)"

Phrase: "or"

Phrase: "IRdye 800"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0966676:IRDye 800 [Organic Chemical,Pharmacologic Substance]

Phrase: "(Rockland Immunochemicals"

Phrase: ")."
Processing 00000000.tx.71: Blots were detected, and bands were sized and quantified using the Odyssey infrared imaging system (LI-COR). 

Phrase: "Blots"

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "and"

Phrase: "bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "sized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Odyssey infrared imaging system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C2697665:Imaging System [Manufactured Object]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(LI-COR)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018787:Cor [Body Part, Organ, or Organ Component]
   861   C0056331:COR [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.72: ACE Activity AssayACE proteolytic activity was assayed using the substrate hippuryl-L-histidyl-L-leucine (Hip-His-Leu; Sigma) as described previously (34), with several modifications. 

Phrase: "ACE Activity AssayACE proteolytic activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0597304:Proteolytic [Molecular Function]
   795   C1947941:proteolytic [Enzyme]
   710   C2258685:angiotensin converting enzyme activity [Molecular Function]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the substrate hippuryl-L-histidyl-L-leucine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   947   C0062727:hippuryl-L-histidyl-L-leucine [Amino Acid, Peptide, or Protein]
           hippuryl-histidyl-leucine
   799   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Hip-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019552:Hip [Body Part, Organ, or Organ Component]
  1000   C0022122:Hip [Body Part, Organ, or Organ Component]
  1000   C3538851:HIP [Gene or Genome]

Phrase: "His-Leu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "with several modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.73: Cells were lysed in 50 mM Tris (pH 7.4) containing 0.5% Nonidet P-40, and nuclei and cell debris was pelleted at 1,000 x g for 10 min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in 50 mM Tris"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0024348:lysed [Pathologic Function]
   760   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "cell debris"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]

Phrase: "was"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "at 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "000 x g for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0560021:g/min [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.74: To assay ACE activity, 2.5 g of cell lysate was incubated with 1 mM Hip-His-Leu in 0.4 M sodium borate buffer (pH 8.3) with 0.3 M NaCl in a total volume of 35 l for 5-60 min at 37 C. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "ACE activity,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C2258685:angiotensin converting enzyme activity [Molecular Function]
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   861   C0243102:enzyme activity [Molecular Function]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "2.5 g of cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0524983:G cell [Cell]
   753   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with 1 mM Hip-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0121811:HIP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1418486:MM-1 [Gene or Genome]
   797   C2348977:HIP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0019552:Hip [Body Part, Organ, or Organ Component]
   760   C0022122:Hip [Body Part, Organ, or Organ Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C3538851:HIP [Gene or Genome]

Phrase: "His-Leu in 0.4 M sodium borate buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0062762:His-Leu [Amino Acid, Peptide, or Protein]
   742   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(pH 8.3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "with 0.3 M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "in a total volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0449468:Total Volume [Quantitative Concept]
           *Volume
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 35 l"

Phrase: "for 5-60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "at 37 C."
Processing 00000000.tx.75: When assaying samples with captopril, a 15-min preincubation with the drug was performed at 4 C before substrate addition. 

Phrase: "When"

Phrase: "assaying samples with captopril,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "a 15-min preincubation with the drug"

Phrase: "was"

Phrase: "performed at 4 C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "before substrate addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.76: Time 0 values were calculated by the addition of EDTA to a final concentration of 10 mM prior to the addition of Hip-His-Leu. 

Phrase: "Time 0 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated by the addition of EDTA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1883712:Addition [Functional Concept]

Phrase: "to a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10 mM"

Phrase: "prior to the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of Hip-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019552:Hip [Body Part, Organ, or Organ Component]
  1000   C0022122:Hip [Body Part, Organ, or Organ Component]
  1000   C3538851:HIP [Gene or Genome]

Phrase: "His-Leu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.77: Enzymatic reactions were terminated by the addition of EDTA (10 mM final concentration). 

Phrase: "Enzymatic reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1511131:Enzymatic Reaction [Molecular Function]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "terminated by the addition of EDTA (10 mM final concentration"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   739   C0086045:Concentration [Mental Process]
   739   C0205088:Final [Temporal Concept]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1546485:Final [Idea or Concept]
   739   C1553404:terminated [Idea or Concept]
   739   C1883712:Addition [Functional Concept]
   739   C2348570:Terminated [Functional Concept]

Phrase: ")."
Processing 00000000.tx.78: Samples were developed first by the addition of 150 l of 0.34 M NaOH, followed by a 10-min room temperature incubation with 20 l of 20 mg/ml o-phthaldialdehyde (Sigma). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "developed"

Phrase: "first by the addition of 150 l of 0.34 M NaOH,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   736   C0205435:First [Quantitative Concept]
   736   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0441923:M+ [Intellectual Product]
   736   C1279901:First [Qualitative Concept]
   736   C1883712:Addition [Functional Concept]

Phrase: "followed by a 10-min room temperature incubation"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0332283:Followed by [Temporal Concept]
           followed
   770   C0456692:/10 min [Temporal Concept]
   770   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   744   C0005903:temperature [Organism Attribute]
   744   C0039476:*Temperature [Quantitative Concept]
   744   C0702093:/min [Temporal Concept]
   744   C1547703:Room [Spatial Concept]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "with 20 l"

Phrase: "of 20 mg/ml o-phthaldialdehyde"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: This reaction was terminated by acidification with 50 l of 3 N HCl. 

Phrase: "This reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by acidification"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1522821:acidification [Cell Function]
   790   C1553404:terminated [Idea or Concept]
   790   C2348570:Terminated [Functional Concept]
   790   C2987513:Acidification [Phenomenon or Process]
   718 E C0011065:Expired [Organism Function]
   718 E C0231800:Expired [Organ or Tissue Function]
   718 E C1704631:Expire [Idea or Concept]

Phrase: "with 50 l"

Phrase: "of 3 N HCl."
Processing 00000000.tx.80: Fluorescence of liberated and o-phthaldialdehyde-modified His-Leu was assayed in a 96-well plate format using a Victor2 multilabel plate reader (excitation, 355; emission, 535) (PerkinElmer Life Sciences). 

Phrase: "Fluorescence of liberated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0016315:Fluorescence [Natural Phenomenon or Process]
   718 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "o-phthaldialdehyde-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028752:o-Phthaldialdehyde [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0439114:O NOS [Intellectual Product]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "His-Leu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "assayed in a 96-well plate format"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   757   C0441685:Plate assay [Laboratory Procedure]
   748   C0005971:Plate [Medical Device]
   748   C0205170:Well [Qualitative Concept]
   748   C1139930:plate [Medical Device]
   748   C1301627:Format [Intellectual Product]
   748   C3146287:Well [Manufactured Object]
   748   C3537155:Plate [Manufactured Object]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Victor2 multilabel plate reader"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514743:Reader [Professional or Occupational Group]
   812   C1706461:Reader [Manufactured Object]

Phrase: "(excitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "355"

Phrase: "; emission,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233929:Emission [Body Substance]
  1000   C2349995:Emission [Substance]

Phrase: "535"

Phrase: ")"

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")."
Processing 00000000.tx.81: 100% degradation was defined as the maximal fluorescence signal achieved by digestion of 1 mM Hip-His-Leu with 2.5 g of ACE-transfected cell lysate for 60 min. 

Phrase: "100% degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "defined as the maximal fluorescence signal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0205289:Maximal [Qualitative Concept]
   753   C0806909:Maximal [Quantitative Concept]
   753   C1704788:Defined [Conceptual Entity]
   753   C1710082:Signal [Phenomenon or Process]
   753   C3539106:Defined [Intellectual Product]

Phrase: "achieved by digestion of 1 mM Hip-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0121811:HIP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1418486:MM-1 [Gene or Genome]
   774   C2348977:HIP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0012238:Digestion [Organism Function]
   748   C0019552:Hip [Body Part, Organ, or Organ Component]
   748   C0022122:Hip [Body Part, Organ, or Organ Component]
   748   C2349986:Digestion [Research Activity]
   748   C3538851:HIP [Gene or Genome]

Phrase: "His-Leu with 2.5 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0062762:His-Leu [Amino Acid, Peptide, or Protein]
   753   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "of ACE-transfected cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "for 60 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.82: Enzyme-linked Immunosorbant AssayConditioned medium samples were harvested by removing cellular debris by centrifugation at 700 x g for 10 min, and protease inhibitors were added (final concentration of 5 g/ml leupeptin, 5 g/ml aprotinin, 2 g/ml pepstatin, 2 mM 1,10-phenanthroline, and 5 mM EDTA). 

Phrase: "Enzyme-linked Immunosorbant AssayConditioned medium samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C0370003:Sample [Substance]
   766   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "harvested by removing cellular debris"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0440266:Debris [Substance]
   726   C0849355:remove [Qualitative Concept]
   726   C1512335:Harvest [Health Care Activity]
   726   C1883720:Remove [Activity]
   726   C3244314:remove [Functional Concept]

Phrase: "by centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 700 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "(final concentration of 5 g/ml leupeptin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "5 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "2 g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "2 mM 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1418486:MM-1 [Gene or Genome]
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "and"

Phrase: "5 mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.83: ELISAs for A were performed as previously described (35), with the following modifications. 

Phrase: "ELISAs for A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0014441:ELISA [Laboratory Procedure]

Phrase: "were"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "with the following modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.84: 96-Well ELISA plates (Costar) were coated with 3.5 g/ml of the capture antibody. 

Phrase: "96-Well ELISA plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1139930:plates [Medical Device]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]

Phrase: "(Costar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140299:COSTAR [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "coated with 3.5 g/ml of the capture antibody."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C1300565:g/mL [Quantitative Concept]
   757   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C1637390:mL/g [Quantitative Concept]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0439267:g% [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C1522408:Coated [Qualitative Concept]
   706 E C0453946:Coat [Manufactured Object]
   706 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.85: A-(1-40) and A-(1-42) were measured by capturing with antibodies specific to the A C-terminal 40 (2G3) or 42 (21F12) residues. 

Phrase: "A-(1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A-(1-42"

Phrase: ")"

Phrase: "were"

Phrase: "measured by capturing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific to the A C-terminal 40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]

Phrase: "(2G3"

Phrase: ")"

Phrase: "or"

Phrase: "42"

Phrase: "(21F12"

Phrase: ")"

Phrase: "residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.86: Captured A was detected with 0.1 g/ml biotinylated 3D6, specific to residues 1-5 of the A N terminus. 

Phrase: "Captured"

Phrase: "A"

Phrase: "was"

Phrase: "detected with 0.1 g/ml"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1300565:g/mL [Quantitative Concept]
   783   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "biotinylated"

Phrase: "3D6,"

Phrase: "specific to residues 1-5 of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]

Phrase: "A N terminus."
Processing 00000000.tx.87: ELISAs measuring X-40 or X-42 forms of A were captured identically with 2G3 or 21F12 and detected with 0.1 g/ml biotinylated 266, specific to residues 13-28 of A. 

Phrase: "ELISAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0014441:ELISA [Laboratory Procedure]

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "X-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "or"

Phrase: "X-42 forms of A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "captured"

Phrase: "identically with 2G3"

Phrase: "or"

Phrase: "21F12"

Phrase: "and"

Phrase: "detected with 0.1 g/ml"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1300565:g/mL [Quantitative Concept]
   783   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "biotinylated"

Phrase: "266,"

Phrase: "specific to residues 13-28 of A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
Processing 00000000.tx.88: Total A was measured by capture with antibody 266 and detection with 0.1 g/ml biotinylated 3D6 (all antibodies gift of Elan Pharmaceuticals, San Francisco, CA). 

Phrase: "Total A"

Phrase: "was"

Phrase: "measured by capture"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "with antibody 266"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "detection with 0.1 g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "biotinylated"

Phrase: "3D6"

Phrase: "("

Phrase: "all antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "gift of Elan Pharmaceuticals,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1135440:Pharmaceuticals [Therapeutic or Preventive Procedure]
   770   C1254351:Pharmaceuticals [Pharmacologic Substance]
   737 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.89: ELISA development was accomplished by incubating the A-bound biotinylated detection antibody with Avidin-horseradish peroxidase (Vector), followed by tetramethylbenzidine-ELISA (Pierce). 

Phrase: "ELISA development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "was"

Phrase: "accomplished by incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:incubating [Laboratory Procedure]

Phrase: "the A-"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "biotinylated detection antibody with Avidin-horseradish peroxidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0430425:Antibody detection [Laboratory Procedure]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "followed by tetramethylbenzidine-ELISA (Pierce"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0014441:ELISA [Laboratory Procedure]
   760   C0046880:Tetramethylbenzidine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   726 E C1719822:Follow [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.90: Plates were washed three times for 1 min after each incubation with Tris-buffered saline, 0.05% Tween 20. 

Phrase: "Plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times for 1 min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "after each incubation"

Phrase: "with Tris-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "0.05% Tween 20."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.91: Statistical AnalysesThe data were analyzed using a one-way analysis of variance and Tukey's post hoc comparison or a two-way analysis of variance and Bonferroni post hoc comparison, where appropriate. 

Phrase: "Statistical AnalysesThe data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C2828391:statistical data [Quantitative Concept]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a one-way analysis of variance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   938   C1709320:One-way Analysis of Variance [Quantitative Concept]
   833   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Tukey's post hoc comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707455:Comparison [Activity]

Phrase: "or"

Phrase: "a two-way analysis of variance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   938   C1710497:Two-way Analysis of Variance [Quantitative Concept]
   833   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Bonferroni post hoc comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707455:Comparison [Activity]

Phrase: "where appropriate."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1548787:Appropriate [Qualitative Concept]
   789 E C0814634:appropriateness [Qualitative Concept]
Processing 00000000.tx.92: Calculated comparisons of p < 0.05 were considered significant.  

Phrase: "Calculated comparisons of p < 0.05"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "significant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.93: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Expression and Characterization of Transfected Human ACETo determine the regional distribution of ACE within the brain, we first dissected several murine brain and peripheral tissues to assess relative ACE content, particularly in AD-relevant brain regions. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Characterization of Transfected Human ACETo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "determine"

Phrase: "the regional distribution of ACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "within the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: "several murine brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "peripheral tissues to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "relative ACE content,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "particularly in AD-relevant brain regions."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1273723:brain regions [Body Location or Region]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0006111:Brain Disease [Disease or Syndrome]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0012634:Disease [Disease or Syndrome]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C2347946:Relevant [Qualitative Concept]
   732   C1514819:Regional Disease [Finding]
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]
Processing 00000000.tx.94: As previously reported, we found that ACE was highly expressed in kidney and lung but absent in the liver (36). 

Phrase: "As"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "expressed in kidney"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0022646:Kidney [Body Part, Organ, or Organ Component]
   790   C0227665:kidney [Body Part, Organ, or Organ Component]
   790   C1278978:Kidney [Body Part, Organ, or Organ Component]
   790   C1514845:KIDNEY [Tissue]

Phrase: "and"

Phrase: "lung"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "but"

Phrase: "absent in the liver"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.95: In the brain, we observed similar expression of ACE protein in the cerebral cortex, hippocampus, cerebellum, and basal ganglia/brainstem (Fig. 1A). 

Phrase: "In the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "similar expression of ACE protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "and"

Phrase: "basal ganglia/brainstem"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
   827   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   734   C0004781:Basal Ganglia [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.96: ACE in each of these brain regions was found to electrophorese as two distinct bands, consisting of the typical full-length 180-kDa species and a higher molecular weight species, the latter reported to arise from alternative glycosylation of ACE in the brain (37). 

Phrase: "ACE in each of these brain regions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   742   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "was"

Phrase: "found to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0150312:Found [Quantitative Concept]
   799 E C0243095:Find [Finding]

Phrase: "electrophorese as two distinct bands,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0013855:electrophorese [Laboratory Procedure]
   760   C0175723:Bands [Medical Device]
   760   C0205448:Two [Quantitative Concept]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "consisting of the typical full-length 180-kDa species"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0443225:Full [Qualitative Concept]
   742   C1444754:Length [Quantitative Concept]
   742   C1532717:kDa [Quantitative Concept]
   742   C1705920:Species [Conceptual Entity]
   742   C1706316:LENGTH [Research Activity]
   742   C3538928:Typical [Qualitative Concept]
   708   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "a higher molecular weight species,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1705920:Species [Conceptual Entity]
   740   C1979900:High molecular weight [Qualitative Concept]

Phrase: "the latter"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "arise from alternative glycosylation of ACE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0017982:glycosylation [Natural Phenomenon or Process]
   744   C0376322:Glycosylation [Molecular Function]
   744   C1523987:Alternative [Conceptual Entity]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.97: To characterize ACE at a cellular level, we cloned the full-length 4.0-kb cDNA from the human neuroblastoma cell line SK-N-SH. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "ACE at a cellular level,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   774   C0014440:enzyme level [Laboratory Procedure]
   774   C1287349:Enzyme level [Laboratory or Test Result]
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the full-length 4.0-kb cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from the human neuroblastoma cell line SK-N-SH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0038108:SH [Geographic Area]
Processing 00000000.tx.98: ACE cDNA was then cloned into the mammalian expression vector pcDNA5/FRT and shown to conform to the reported human ACE sequence by both restriction mapping and DNA sequencing. 

Phrase: "ACE cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cloned into the mammalian expression vector pcDNA5/FRT"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0009013:cloned [Cell]
   744   C0024660:Mammalian [Mammal]
   744   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0442335:Vector [Spatial Concept]
   744   C1705099:Vector [Idea or Concept]
   744   C1705150:FRT [Gene or Genome]
   711 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conform to the reported human ACE sequence"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   742   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0086418:Human [Human]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C1519249:Sequence [Functional Concept]
   742   C3496591:Reported [Clinical Attribute]
   708 E C3273238:Report [Intellectual Product]

Phrase: "by both restriction mapping"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0035269:Restriction Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0443288:Restriction [Functional Concept]
   861   C1283195:Mapping [Activity]
   827 E C0024779:Map [Manufactured Object]
   827 E C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "DNA sequencing."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162326:DNA sequencing [Nucleotide Sequence]
  1000   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.99: Transient transfection of the ACE construct into CHO and HEK293 cells yielded indistinguishable results in all assays performed (Fig. 2). 

Phrase: "Transient transfection of the ACE construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "into CHO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "HEK293 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   897   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   836   C0553257:kidney cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "yielded"

Phrase: "indistinguishable results in all assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.100: Neither cell line expressed detectable endogenous levels of ACE protein by Western blotting, although ACE mRNA was detected in HEK293 cells by reverse transcription-PCR (data not shown). 

Phrase: "Neither cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "expressed"

Phrase: "detectable endogenous levels of ACE protein"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C0014440:enzyme levels [Laboratory Procedure]
   767   C1287349:enzyme levels [Laboratory or Test Result]
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "by Western blotting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "although"

Phrase: "ACE mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "was"

Phrase: "detected in HEK293 cells"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   774   C0427861:Human cells [Laboratory or Test Result]
   774   C0553257:cells kidney [Cell]
   757   C1947950:Embryonic Cell [Embryonic Structure]
   748   C0007634:Cells [Cell]
   748   C0013935:Embryonic [Embryonic Structure]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C0442726:Detected [Finding]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1514845:KIDNEY [Tissue]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "by reverse transcription-PCR (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.101: ACE is predicted to contain 17 N-type glycosylation sites and no O-type glycosylation sites. 

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "17 N-type glycosylation sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0017982:glycosylation [Natural Phenomenon or Process]
   804   C0205145:Sites [Spatial Concept]
   804   C0376322:Glycosylation [Molecular Function]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "no O-type glycosylation sites."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0017982:glycosylation [Natural Phenomenon or Process]
   812   C0205145:Sites [Spatial Concept]
   812   C0376322:Glycosylation [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.102: To determine whether transfected ACE protein was processed similarly to tissue-derived ACE, we compared glycosylation patterns of mouse kidney tissue ACE and ACE transfected into either CHO or HEK293 cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "transfected ACE protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "was"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "similarly to tissue-derived ACE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0040300:Tissue [Tissue]
   748   C1441547:Derived [Qualitative Concept]
   748   C1547928:Tissue [Intellectual Product]
   748   C3245521:derived [Idea or Concept]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "glycosylation patterns of mouse kidney tissue ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "transfected into either CHO"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0007634:Cell [Cell]
   748   C0018557:Hamster [Mammal]
   748   C0029939:Ovary [Body Part, Organ, or Organ Component]
   748   C0227898:ovary [Body Part, Organ, or Organ Component]
   748   C1269647:Cell [Cell]
   748   C1278992:Ovary [Body Part, Organ, or Organ Component]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "HEK293 cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   897   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   836   C0553257:kidney cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.103: As expected, deglycosylation with several enzymes specific to O-linked sugars produced no shift in ACE size, whereas removal of N-linked modifications yielded a shift in the ACE protein from 182 to 154 kDa (Fig. 2A). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "deglycosylation with several enzymes"

Phrase: "specific to O-linked sugars"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "produced"

Phrase: "no shift in ACE size,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "whereas"

Phrase: "removal of N-linked modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "yielded"

Phrase: "a shift in the ACE protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0333051:Shift [Functional Concept]
   744   C2347509:Shift [Phenomenon or Process]

Phrase: "from 182"

Phrase: "to 154 kDa (Fig. 2A"

Phrase: ")."
Processing 00000000.tx.104: ACE is known to be secreted both in vivo and in vitro from the cell surface at low levels in an -secretase-dependent manner (38). 

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "both in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro from the cell surface"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]

Phrase: "at low levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "in an -secretase-dependent manner"

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.105: The concentration of conditioned medium from HEK293 and CHO cells transiently transfected with ACE cDNA was found to contain low levels of ACE protein, whereas control cells transfected with the empty vector had no corresponding signal (Fig. 2B). 

Phrase: "The concentration of conditioned medium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "from HEK293"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0013935:Embryonic [Embryonic Structure]
   812   C0022646:Kidney [Body Part, Organ, or Organ Component]
   812   C0086418:Human [Human]
   812   C0227665:kidney [Body Part, Organ, or Organ Component]
   812   C1278978:Kidney [Body Part, Organ, or Organ Component]
   812   C1514845:KIDNEY [Tissue]
   719 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "CHO cells transiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]

Phrase: "transfected with ACE cDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "low levels of ACE protein,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   789   C0748025:Low protein level [Finding]
   774   C0014440:enzyme levels [Laboratory Procedure]
   774   C1287349:enzyme levels [Laboratory or Test Result]
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "whereas"

Phrase: "control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1880497:Empty [Qualitative Concept]
   704 E C0333668:Depleted [Functional Concept]

Phrase: "had"

Phrase: "no corresponding signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.106: View larger version (37K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.107: Brain distribution and schematic diagram of angiotensin-converting enzyme. 

Phrase: "Brain distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "schematic diagram of angiotensin-converting enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681494:Diagram [Intellectual Product]
Processing 00000000.tx.108: A, 20 g of murine tissue homogenates from the designated brain regions, as well as peripheral tissues known to lack or highly express ACE, were probed by Western blotting with an ACE-specific antibody. 

Phrase: "A,"

Phrase: "20 g of murine tissue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "homogenates from the designated brain regions,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1273723:brain regions [Body Location or Region]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1524084:Designated [Functional Concept]
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "as well as"

Phrase: "peripheral tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "or"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "express"

Phrase: "ACE,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "were"

Phrase: "probed by Western blotting"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "with an ACE-specific antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
Processing 00000000.tx.109: Note that brain ACE occurs as a doublet, arising from alternate glycosylation. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that brain ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "occurs as a doublet,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "arising from alternate glycosylation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017982:glycosylation [Natural Phenomenon or Process]
   770   C0332270:alternate [Functional Concept]
   770   C0332284:arising [Qualitative Concept]
   770   C0376322:Glycosylation [Molecular Function]
   770   C1523987:Alternate [Conceptual Entity]
Processing 00000000.tx.110: The asterisk indicates a nonspecific band detected only in liver, as has been previously reported (46). 

Phrase: "The asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "indicates"

Phrase: "a nonspecific band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only in liver,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0205171:Only [Quantitative Concept]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C1720467:Only [Intellectual Product]
   790   C2346688:LIVER [Food]
   734 E C0205054:Hepatic [Body Location or Region]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.111: B, schematic representation of the human full-length ACE protein. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "schematic representation of the human full-length ACE protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1514861:Representation [Conceptual Entity]
   738   C1882932:Representation [Activity]
Processing 00000000.tx.112: The wild-type enzyme contains a signal peptide (SP), two homologous catalytic domains (gray boxes), a single transmembrane segment (TM), and a small C-terminal cytoplasmic tail. 

Phrase: "The wild-type enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a signal peptide (SP),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037081:Signal Peptide [Amino Acid Sequence]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "two homologous catalytic domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0600499:Domains, Catalytic [Amino Acid Sequence]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "(gray boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "a single transmembrane segment (TM),"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0441635:Segment [Spatial Concept]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   755 E C0205122:Segmental [Spatial Concept]

Phrase: "and"

Phrase: "a small C-terminal cytoplasmic tail."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1511625:Cytoplasmic Tail [Cell Component]
   804   C0010834:Cytoplasmic [Cell Component]
   804   C0039259:Tail [Body Part, Organ, or Organ Component]
   804   C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.113: The metalloprotease catalytic sequence of each domain is indicated, with the corresponding amino acid numbering from the first N-terminal residue of the mature protein.  

Phrase: "The metalloprotease catalytic sequence of each domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "is"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "with the corresponding amino acid numbering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C0546742:Acid number [Laboratory Procedure]
   812   C0449788:numbering [Quantitative Concept]
   779 E C0237753:*Number [Quantitative Concept]

Phrase: "from the first N-terminal residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1709915:Residue [Conceptual Entity]
   812   C1882936:RESIDUE [Phenomenon or Process]
   741 E C1609982:Residual [Qualitative Concept]

Phrase: "of the mature protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.114: To determine whether the transfected ACE was enzymatically active, we incubated lysates from cells transiently transfected with ACE or empty vector with the commonly used synthetic ACE substrate, Hip-His-Leu, under standard assay conditions (1 mM substrate, 2.5 g of cell lysate, 0.4 M sodium borate buffer, and 0.3 M NaCl, pH 8.3) for 30 min at 37 C. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the transfected ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "enzymatically active,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "we"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "lysates from cells transiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   786   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "transfected with ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   760   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "or"

Phrase: "empty vector with the commonly"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1880497:Empty [Qualitative Concept]
   704 E C0333668:Depleted [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synthetic ACE substrate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0178623:enzyme substrate [Chemical Viewed Functionally]
   804   C1710236:Substrate [Manufactured Object]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   708   C0597548:synthetic enzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Hip-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019552:Hip [Body Part, Organ, or Organ Component]
  1000   C0022122:Hip [Body Part, Organ, or Organ Component]
  1000   C3538851:HIP [Gene or Genome]

Phrase: "His-Leu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "under standard assay conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(1 mM substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "2.5 g of cell lysate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0524983:G cell [Cell]
   753   C0439267:g% [Quantitative Concept]

Phrase: "0.4 M sodium borate buffer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0991799:BORATE BUFFER [Pharmacologic Substance]
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.3 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 8.3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37 C."
Processing 00000000.tx.115: Lysates from cells transfected with ACE exhibited robust degradation of Hip-His-Leu, and this was completely blocked by a 1 M concentration of the competitive ACE inhibitor, captopril. 

Phrase: "Lysates from cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   824   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "transfected with ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   760   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "robust degradation of Hip-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "His-Leu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "this"

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked by a 1 M concentration"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0028778:Blocked [Pathologic Function]
   753   C0086045:Concentration [Mental Process]
   753   C0332206:Blocked [Functional Concept]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1446561:Concentration [Quantitative Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "of the competitive ACE inhibitor,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   937   C0003015:Angiotensin-converting enzyme inhibitor [Pharmacologic Substance]
   937   C2757044:Angiotensin Converting Enzyme Inhibitor [Molecular Function]
   937   C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   840   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   840   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C1999216:Inhibitor [Qualitative Concept]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "captopril."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.116: In contrast, lysates from cells transfected with empty vector had no detectable ACE activity (Fig. 2C). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "lysates from cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   824   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "transfected with empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1880497:Empty [Qualitative Concept]
   715 E C0333668:Depleted [Functional Concept]

Phrase: "had"

Phrase: "no detectable ACE activity"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   937   C2258685:angiotensin converting enzyme activity [Molecular Function]
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   840   C0243102:enzyme activity [Molecular Function]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.117: Taken together, the above results demonstrate that the cloned and transfected ACE construct is processed similarly to tissue ACE and retains proteolytic activity and sensitivity to ACE inhibitors. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the above results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "transfected ACE construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2827421:Construct [Classification]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "is"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "similarly to tissue ACE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0040300:Tissue [Tissue]
   753   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C0597304:Proteolytic [Molecular Function]
   861   C1561536:*Activity [Idea or Concept]
   861   C1947941:proteolytic [Enzyme]

Phrase: "and"

Phrase: "sensitivity to ACE inhibitors."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   754   C0332324:Sensitive to [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]
   716   C0003015:Angiotensin-Converting Enzyme Inhibitors [Pharmacologic Substance]
   716   C2757044:Angiotensin-converting Enzyme Inhibitors [Molecular Function]
Processing 00000000.tx.118: Transiently Expressed ACE Promotes Clearance and Secondary Degradation of ATo determine whether ACE can modulate A levels in intact, living cells, we transiently transfected equal DNA amounts of plasmids encoding either empty vector, IDE, or ACE in pcDNA5/FRT into HEK293 cells stably expressing human APP695 bearing the Swedish AD-causing mutation and measured the levels of A in the resulting conditioned medium. 

Phrase: "Transiently Expressed ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "Promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "Secondary Degradation of ATo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "determine"

Phrase: "whether"

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A levels in intact,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "living"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0376558:Living [Idea or Concept]
   966 E C1548795:Live [Qualitative Concept]
   966 E C1634625:% live [Qualitative Concept]
   966 E C2982691:Live [Activity]

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "we transiently"

Phrase: "transfected"

Phrase: "equal DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "amounts of plasmids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1265611:Amount [Quantitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "either empty vector,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]
   827   C1880497:Empty [Qualitative Concept]
   771 E C0333668:Depleted [Functional Concept]
   743 E C1550032:Unload [Idea or Concept]
   743 E C1996907:Emptying [Activity]

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "ACE in pcDNA5/FRT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "into HEK293 cells stably"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   876   C0427861:Human cells [Laboratory or Test Result]
   841   C1947950:Embryonic Cell [Embryonic Structure]
   822   C0553257:kidney cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human APP695"

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the Swedish AD-causing mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C2985434:Disease-causing Mutation [Cell or Molecular Dysfunction]
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the levels of A in the resulting conditioned medium."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.119: Transfection of HA-tagged IDE served as a positive control for A proteolysis, since this has been shown to lower A in cultured cells (6, 39). 

Phrase: "Transfection of HA-tagged IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "served as a positive control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "for A proteolysis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "since"

Phrase: "this"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "A in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(6,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.120: Using an ELISA specific to A-(1-40) and A-(1-42), IDE was found to reduce cell-derived A levels to 55 and 47%, respectively, of those in control cells transfected with empty vector (p < 0.001 for both comparisons). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "specific to A-(1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "A-(1-42"

Phrase: ")"

Phrase: ","

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "cell-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "A levels to 55"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "47%,"

Phrase: "respectively,"

Phrase: "of those in control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0007634:Cells [Cell]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1880497:Empty [Qualitative Concept]
   715 E C0333668:Depleted [Functional Concept]

Phrase: "(p < 0.001 for both comparisons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C2603361:P' [Clinical Attribute]
   719   C1707455:Comparison [Activity]

Phrase: ")."
Processing 00000000.tx.121: Transfections with ACE yielded similar results, reducing A-(1-42) levels to 70% and A-(1-42) levels to 61% of control (p < 0.05 for A-(1-40) and p < 0.01 for A-(1-42)) (Fig. 3A). 

Phrase: "Transfections with ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "yielded"

Phrase: "similar results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "A-(1-42"

Phrase: ")"

Phrase: "levels to 70%"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A-(1-42"

Phrase: ")"

Phrase: "levels to 61% of control"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(p < 0.05 for A-(1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "p < 0.01 for A-(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ")"

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.122: Thus, both ACE- and IDE-transfected cells had significantly reduced levels of both principal A species compared with control but were not significantly different from each other. 

Phrase: "Thus,"

Phrase: "both ACE-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "IDE-transfected cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   881   C0030281:Insulin Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "had"

Phrase: "significantly reduced levels of both principal"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "but"

Phrase: "were"

Phrase: "not significantly different from each other."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.123: View larger version (26K): [in this window] [in a new window]  FIGURE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 2."
Processing 00000000.tx.124: Characterization of the processing and enzymatic activity of cloned human ACE. 

Phrase: "Characterization of the processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "enzymatic activity of cloned human ACE."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   822   C2258685:angiotensin converting enzyme activity [Molecular Function]
   770   C2267219:Enzymatic Activity [Molecular Function]
   767   C0020115:Human Activity [Activity]
   767   C0243102:enzyme activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.125: A, lysates from mouse kidney or CHO cells transiently transfected with the ACE cDNA construct were subjected to deglycosylation with enzymes specific to N- or O-linked sugars and subject to Western blot analysis with an ACE-specific antibody. 

Phrase: "A,"

Phrase: "lysates from mouse kidney"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1881488:Lysate [Physical Object]

Phrase: "or"

Phrase: "CHO cells transiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]

Phrase: "transfected with the ACE cDNA construct"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "subjected to deglycosylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "specific to N-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "O-linked sugars"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0242209:Sugars [Carbohydrate,Pharmacologic Substance]
   793 E C0007004:Sugar [Carbohydrate]

Phrase: "and subject to Western blot analysis"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0681850:Subject [Group]
   753   C0936012:Analysis [Research Activity]
   753   C1515981:And [Idea or Concept]
   753   C1524024:analysis [Functional Concept]
   753   C1550501:{Subject} [Idea or Concept]
   753   C1705493:Western [Spatial Concept]
   753   C1706203:Subject [Idea or Concept]
   753   C2349001:Subject [Human]
   753   C2697811:Subject [Functional Concept]

Phrase: "with an ACE-specific antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
Processing 00000000.tx.126: The asterisk indicates the calculated molecular weight of the deglycosylated band. 

Phrase: "The asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "indicates"

Phrase: "the calculated molecular weight of the deglycosylated band."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0026385:Molecular Weight [Quantitative Concept]
   744   C0005910:weight [Organism Attribute]
   744   C0043100:Weight [Quantitative Concept]
   744   C1305866:weight [Diagnostic Procedure]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1705104:Weight [Idea or Concept]
Processing 00000000.tx.127: B, conditioned medium from CHO cells transiently transfected with ACE or empty vector was concentrated and analyzed by Western blot, reflecting a low rate of ACE ectodomain secretion (sACE), as previously reported (12). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "conditioned medium from CHO cells transiently"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   742   C0009458:Medium [Intellectual Product]
   742   C0439536:Medium [Quantitative Concept]
   742   C1705217:Medium [Substance]
   742   C3244283:medium [Intellectual Product]

Phrase: "transfected with ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   760   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "or"

Phrase: "empty vector"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "was"

Phrase: "concentrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]

Phrase: "and"

Phrase: "analyzed by Western blot,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "a low rate of ACE ectodomain secretion (sACE),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.128: C, ACE enzymatic activity was measured by incubating 2.5 g of lysate from HEK293 cells transfected with the indicated constructs with 1 mM of the substrate Hip-His-Leu for 30 min at 37 C. 

Phrase: "C,"

Phrase: "ACE enzymatic activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   933   C2258685:angiotensin converting enzyme activity [Molecular Function]
   853   C0243102:enzyme activity [Molecular Function]
   840   C2267219:Enzymatic Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "was"

Phrase: "measured by incubating 2.5 g of lysate"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0439267:g% [Quantitative Concept]
   744   C0444706:Measured [Qualitative Concept]
   744   C1439852:incubating [Laboratory Procedure]
   744   C1881488:Lysate [Physical Object]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "from HEK293 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   897   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   836   C0553257:kidney cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the indicated constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444656:Indicated [Finding]
   726   C2827421:Construct [Classification]

Phrase: "with 1 mM"

Phrase: "of the substrate Hip-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019552:Hip [Body Part, Organ, or Organ Component]
   861   C0022122:Hip [Body Part, Organ, or Organ Component]
   861   C3538851:HIP [Gene or Genome]

Phrase: "His-Leu for 30 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0062762:His-Leu [Amino Acid, Peptide, or Protein]
   760   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "at 37 C."
Processing 00000000.tx.129: 100% degradation was defined as the maximal fluorescence produced by 60 min of substrate incubation with 2.5 g of lysate from cells transfected with the ACE cDNA. 

Phrase: "100% degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "defined as the maximal fluorescence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0205289:Maximal [Qualitative Concept]
   760   C0806909:Maximal [Quantitative Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "produced by 60 min of substrate incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0702093:/min [Temporal Concept]
   748   C1710236:Substrate [Manufactured Object]

Phrase: "with 2.5 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439267:g% [Quantitative Concept]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "of lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881488:Lysate [Physical Object]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the ACE cDNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
Processing 00000000.tx.130: Values in C represent the means  S.E. obtained from four independent experiments. 

Phrase: "Values in C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "obtained from four independent experiments."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0085862:Independent [Idea or Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.131: Each blot in A and B is representative of at least four independent experiments. 

Phrase: "Each blot in A"

Phrase: "and"

Phrase: "B is"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least four independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.132: Deglycosylation, secretion, and enzymatic activity assays were identical for transfected CHO and HEK293 cell lines.  

Phrase: "Deglycosylation,"

Phrase: "secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "enzymatic activity assays"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   913   C2717977:Enzymatic Assays [Laboratory Procedure]
   901   C2267219:Enzymatic Activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "identical for transfected CHO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]

Phrase: "and"

Phrase: "HEK293 cell lines."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   887   C0682523:Human Cell Line [Cell]
   876   C0427861:human cell [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   839   C0553257:kidney cell [Cell]
   827   C0007600:Cell lines [Cell]
   799   C0007634:Cell [Cell]
   799   C0205132:lines [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.133: Because ACE has been shown to cleave A between Asp7 and Ser8 in vitro (30), we hypothesized that the remaining A fragment, beginning at Ser8, might either accumulate or undergo secondary degradation in a cellular context. 

Phrase: "Because"

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "A between Asp7"

Phrase: "and"

Phrase: "Ser8"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527428:Remaining [Qualitative Concept]

Phrase: "A fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "beginning at Ser8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439659:Beginning [Temporal Concept]

Phrase: "might"

Phrase: "either"

Phrase: "accumulate"

Phrase: "or"

Phrase: "undergo"

Phrase: "secondary degradation in a cellular context."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1523935:cellular degradation [Cell Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.134: To discriminate between these possibilities, we used an ELISA specific to internal residues 13-28 of A for capture and to either the 40 or 42 C termini for detection; 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "discriminate between these possibilities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205235:Discriminate [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "specific to internal residues 13-28 of A for capture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205369:Specific [Qualitative Concept]
   739   C1552740:specific [Intellectual Product]

Phrase: "and to either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "the 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "or"

Phrase: "42 C termini for detection"

Phrase: ";"
Processing 00000000.tx.135: the measured species are denoted A-(X-40) and A-(X-42). 

Phrase: "the measured species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "denoted"

Phrase: "A-(X-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A-(X-42"

Phrase: ")."
Processing 00000000.tx.136: We found IDE to decrease A-(X-40) levels to 78% and A-(X-42) levels to 68% of those of control cells (p < 0.05 for A-(X-40) and p < 0.001 for A-(X-42)). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "IDE to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "A-(X-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "levels to 78%"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A-(X-42"

Phrase: ")"

Phrase: "levels to 68% of those of control cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "(p < 0.05 for A-(X-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "p < 0.001 for A-(X-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.137: ACE again mirrored this reduction, with A-(X-40) decreased to 79% and A-(X-42) decreased to 71% of controls (p < 0.05 for A-(X-40) and p < 0.001 for A-(X-42)) (Fig. 3B). 

Phrase: "ACE again"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "mirrored"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0181868:mirrored [Manufactured Object]
   966 E C1706183:Mirror [Manufactured Object]

Phrase: "this reduction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "with A-(X-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "decreased to 79%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "A-(X-42"

Phrase: ")"

Phrase: "decreased to 71% of controls"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0450389:71 [Intellectual Product]
   726   C0243148:control [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(p < 0.05 for A-(X-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "p < 0.001 for A-(X-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ")"

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.138: Both A-(X-40) and A-(X-42) values for IDE and ACE were significantly different from control but not different from each other. 

Phrase: "Both A-(X-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A-(X-42"

Phrase: ")"

Phrase: "values for IDE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "were"

Phrase: "significantly different from control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "but"

Phrase: "not different from each other."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.139: Thus, in a human cell line transfected with human cDNAs encoding both APP and either IDE or ACE, A levels were significantly reduced. 

Phrase: "Thus,"

Phrase: "in a human cell line"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0682523:Human Cell Line [Cell]
   901   C0007600:Cell Line [Cell]
   901   C0427861:human cell [Laboratory or Test Result]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "transfected with human cDNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   737   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "both APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "either IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "ACE,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.140: Further, cell-derived A in ACE-transfected cells showed greater secondary degradation of the peptide than has been reported in vitro (30). 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "cell-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "A in ACE-transfected cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   814   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0007634:Cells [Cell]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "greater secondary degradation of the peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1523817:peptide degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "than"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.141: This result suggests that ACE degrades A at additional sites when in a cellular context and/or that A species cleaved by ACE are subsequently degraded by other cellular proteases. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "degrades"

Phrase: "A at additional sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205145:Sites [Spatial Concept]
   770   C1524062:Additional [Functional Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "when in a cellular context"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0449255:Context [Finding]
   760   C0542559:Context [Functional Concept]
   760   C1720477:When [Qualitative Concept]
   760   C1948054:When [Temporal Concept]

Phrase: "and/or"

Phrase: "that"

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "cleaved by ACE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   760   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]

Phrase: "are"

Phrase: "subsequently"

Phrase: "degraded by other cellular proteases."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cellular [Cell]
   760   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0178539:Cellular [Functional Concept]
   760   C1881707:DEGRADED [Phenomenon or Process]
   760   C1947941:Proteases [Enzyme]
Processing 00000000.tx.142: Transfection efficiency was assayed by Western blot analysis (Fig. 3C). 

Phrase: "Transfection efficiency"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:Efficiency [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "was"

Phrase: "assayed by Western blot analysis"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western blot assay
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.143: Whereas both transfected constructs resulted in robust expression, total IDE levels were only increased 2.5-fold over endogenous IDE (Fig. 3C, bottom panel). 

Phrase: "Whereas"

Phrase: "both transfected constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "resulted in robust expression,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C2986815:Robust [Qualitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "total IDE levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   875   C0202098:insulin levels [Laboratory Procedure]
   875   C0428405:insulin levels [Laboratory or Test Result]
   840   C0014440:enzyme levels [Laboratory Procedure]
   840   C1287349:enzyme levels [Laboratory or Test Result]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "were"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2.5-fold over endogenous IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332462:Fold [Spatial Concept]
   744   C1880834:FOLD [Phenomenon or Process]

Phrase: "(Fig. 3C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.144: In contrast, no detectable endogenous ACE was expressed by the HEK293 cells (Fig. 3C, top panel). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "no detectable endogenous ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "expressed by the HEK293 cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   767   C0427861:Human cells [Laboratory or Test Result]
   767   C0553257:cells kidney [Cell]
   750   C1947950:Embryonic Cell [Embryonic Structure]
   744   C0007634:Cells [Cell]
   744   C0013935:Embryonic [Embryonic Structure]
   744   C0022646:Kidney [Body Part, Organ, or Organ Component]
   744   C0086418:Human [Human]
   744   C0227665:kidney [Body Part, Organ, or Organ Component]
   744   C1278978:Kidney [Body Part, Organ, or Organ Component]
   744   C1514845:KIDNEY [Tissue]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.145: Generation of Catalytically Inactive ACE MutantsACE contains two homologous catalytic regions, termed the N- and C-domains, each containing a canonical zinc metalloprotease active site (Fig. 1B). 

Phrase: "Generation of Catalytically Inactive ACE MutantsACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "two homologous catalytic regions,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0600499:Regions, Catalytic [Amino Acid Sequence]
   779   C0017446:Region [Geographic Area]
   779   C0205147:Region [Spatial Concept]
   729 E C0205276:Regional [Spatial Concept]
   729 E C1947913:Regional [Spatial Concept]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "each"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a canonical zinc metalloprotease active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0205681:Active Site [Functional Concept]
   804   C0205145:Site [Spatial Concept]
   804   C0205177:Active [Functional Concept]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.146: To determine which active site mediates A clearance, we generated three ACE mutant constructs: two containing only one functional catalytic domain and one catalytically inactive enzyme bearing mutations in both sites. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "A clearance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "three ACE mutant constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C2827421:Construct [Classification]

Phrase: ":"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "only one functional catalytic domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0600499:Catalytic Domain [Amino Acid Sequence]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "one catalytically inactive enzyme bearing mutations in both sites."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.147: Mutations were made by site-directed mutagenesis to change the active site sequence HEMGH to HDMGH, a conservative mutation previously shown to inactivate ACE proteolysis (11). 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "made by site-directed mutagenesis to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   753   C0079866:Mutagenesis [Molecular Function]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
   753   C3146302:Mutagenesis [Laboratory Procedure]
   719   C0439851:Direct [Qualitative Concept]
   719   C1881534:Make [Functional Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the active site sequence HEMGH to HDMGH,"

Phrase: "a conservative mutation previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inactivate"

Phrase: "ACE proteolysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0597304:Proteolysis [Molecular Function]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   741 E C1947941:proteolytic [Enzyme]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.148: The C-domain was inactivated by mutating ACE glutamate residue 362 to aspartate (termed E362D), and the N-domain was similarly mutated by changing glutamate residue 960 to aspartate (termed E960D). 

Phrase: "The C-domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "inactivated by mutating ACE glutamate residue 362"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   742   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   742   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709915:Residue [Conceptual Entity]
   742   C1882936:RESIDUE [Phenomenon or Process]
   708   C1513776:Mutate [Genetic Function]

Phrase: "to aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(termed E362D"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the N-domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1513868:N Domain [Amino Acid Sequence]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "similarly"

Phrase: "mutated by changing glutamate residue 960"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0392747:Changing [Functional Concept]
   753   C0443172:changing [Quantitative Concept]
   753   C1705285:Mutated [Cell or Molecular Dysfunction]
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]
   719 E C1513776:Mutate [Genetic Function]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "to aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(termed E960D"

Phrase: ")."
Processing 00000000.tx.149: Singly mutated constructs were combined by restriction digestion and ligation to form the catalytically inactive double mutant (E362D/E960D). 

Phrase: "Singly mutated constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "combined by restriction digestion"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0012238:Digestion [Organism Function]
   770   C0205195:Combined [Qualitative Concept]
   770   C0443288:Restriction [Functional Concept]
   770   C2349986:Digestion [Research Activity]
   737 E C0336789:Combine [Manufactured Object]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "ligation to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023690:Ligation [Therapeutic or Preventive Procedure]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the catalytically inactive double mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(E362D/E960D"

Phrase: ")."
Processing 00000000.tx.150: Each construct was analyzed by restriction digestion and DNA sequencing to ensure that no mutations were made outside of those produced by the site-directed mutagenesis. 

Phrase: "Each construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "analyzed by restriction digestion"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0012238:Digestion [Organism Function]
   770   C0443288:Restriction [Functional Concept]
   770   C0936012:Analyzed [Research Activity]
   770   C2349986:Digestion [Research Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "DNA sequencing to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162326:DNA sequencing [Nucleotide Sequence]
   901   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "no mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "made outside of those"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205101:Outside [Spatial Concept]
   737   C1881534:Make [Functional Concept]

Phrase: "produced by the site-directed mutagenesis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   753   C0079866:Mutagenesis [Molecular Function]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
   753   C3146302:Mutagenesis [Laboratory Procedure]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.151: Each was cloned into pcDNA5/FRT to achieve identical levels of cellular expression. 

Phrase: "Each"

Phrase: "was"

Phrase: "cloned into pcDNA5/FRT to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0009013:cloned [Cell]
   760   C1705150:FRT [Gene or Genome]
   726 E C1522642:Clone [Tissue]

Phrase: "achieve"

Phrase: "identical levels of cellular expression."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C3244092:expression level [Idea or Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.152: A CHO cell line stably expressing both human APP751 bearing the AD-causing V717F mutation, and a Flp-In acceptor locus was used to make stable cell lines expressing wild-type ACE (wtACE), E362D, E960D, E362D/E960D, or empty vector. 

Phrase: "A CHO cell line stably"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C0007600:Cell Line [Cell]
   793   C0205132:Line [Spatial Concept]
   793   C1550648:Line [Substance]
   793   C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "both human APP751"

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the AD-causing V717F mutation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   888   C2985434:Disease-causing Mutation [Cell or Molecular Dysfunction]
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "a Flp-In acceptor locus"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "stable cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   983   C0598091:stable cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "wild-type ACE (wtACE),"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "E362D,"

Phrase: "E960D,"

Phrase: "E362D/E960D,"

Phrase: "or"

Phrase: "empty vector."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]
Processing 00000000.tx.153: Thus, each stable cell line contained APP as well as one of the transfected constructs integrated into the same genomic locus by site-directed recombination of the pcDNA5/FRT vector (cell lines are designated as APP + X, where X is the integrated construct). 

Phrase: "Thus,"

Phrase: "each stable cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0598091:stable cell line [Cell]
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "as well as"

Phrase: "one of the transfected constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "integrated into the same genomic locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017428:Genomic [Gene or Genome]
   753   C0445247:Same [Qualitative Concept]
   753   C0887950:genomic [Biomedical Occupation or Discipline]
   753   C1708726:Locus [Gene or Genome]

Phrase: "by site-directed recombination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034865:Recombination [Genetic Function]

Phrase: "of the pcDNA5/FRT vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "(cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "are"

Phrase: "designated as APP + X,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1524084:Designated [Functional Concept]
   770   C3538722:APP [Laboratory Procedure]

Phrase: "where X"

Phrase: "is"

Phrase: "the integrated construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: ")."
Processing 00000000.tx.154: The resulting ACE stable lines produced identical levels of the wtACE or mutant ACE proteins as well as indistinguishable levels of human APP (Fig. 4A). 

Phrase: "The resulting ACE stable lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0205132:lines [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "produced"

Phrase: "identical levels of the wtACE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "mutant ACE proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "as well as"

Phrase: "indistinguishable levels of human APP (Fig. 4A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.155: Notably, the APP + empty vector line expressed an estimated 11% higher level of APP than the four APP + ACE lines (Fig. 4A, middle panel), presumably the result of modest cytomegalovirus promoter competition between the APP and ACE constructs. 

Phrase: "Notably,"

Phrase: "the APP + empty vector line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "expressed"

Phrase: "an estimated 11% higher level of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "than the four APP + ACE lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0205132:lines [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "presumably"

Phrase: "the result of modest cytomegalovirus promoter competition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "between the APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "ACE constructs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C2827421:Construct [Classification]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
Processing 00000000.tx.156: The E362D, E960D, and E362D/E960D mutant proteins were all posttranslationally modified and secreted at similar levels as the wtACE protein (Fig. 4, A and B). 

Phrase: "The E362D,"

Phrase: "E960D,"

Phrase: "and"

Phrase: "E362D/E960D mutant proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "all posttranslationally"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "and"

Phrase: "secreted at similar levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0441889:Levels [Qualitative Concept]
   770   C1327616:Secreted [Cell Function]
   770   C2348205:Similar [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "as the wtACE protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.157: Canonical enzymatic activity of the mutant constructs was confirmed by degradation of the substrate Hip-His-Leu (Fig. 4C). 

Phrase: "Canonical enzymatic activity of the mutant constructs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C2267219:Enzymatic Activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "confirmed by degradation of the substrate Hip-"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   748   C0019552:Hip [Body Part, Organ, or Organ Component]
   748   C0022122:Hip [Body Part, Organ, or Organ Component]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   748   C0750484:Confirmed [Idea or Concept]
   748   C1710236:Substrate [Manufactured Object]
   748   C3538851:HIP [Gene or Genome]
   714 E C1456348:Confirm [Qualitative Concept]

Phrase: "His-Leu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.158: The wtACE and E362D proteins were found to degrade this substrate at similar rates, whereas E960D had a far reduced efficiency of hydrolysis, conforming to the published kinetic parameters of each active site for Hip-His-Leu (11). 

Phrase: "The wtACE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "E362D proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "this substrate at similar rates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710236:Substrate [Manufactured Object]

Phrase: "whereas"

Phrase: "E960D"

Phrase: "had"

Phrase: "a far reduced efficiency of hydrolysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013682:Efficiency [Quantitative Concept]

Phrase: "conforming to the published kinetic parameters of each active site"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   760   C0205681:Active Site [Functional Concept]
   757   C2945843:Site of [Qualitative Concept]
   739   C0022702:kinetic [Natural Phenomenon or Process]
   739   C0034037:Published [Occupational Activity]
   739   C0205145:Site [Spatial Concept]
   739   C0205177:Active [Functional Concept]
   739   C0449381:Parameters [Finding]
   739   C1515974:Site [Body Location or Region]
   739   C1704324:Published [Intellectual Product]
   739   C2825164:Site [Spatial Concept]
   730   C0231481:Active motion [Organism Function]
   706 E C0549193:Parameter [Spatial Concept]
   706 E C1704769:Parameter [Conceptual Entity]
   706 E C2350001:Parameter [Quantitative Concept]

Phrase: "for Hip-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019552:Hip [Body Part, Organ, or Organ Component]
  1000   C0022122:Hip [Body Part, Organ, or Organ Component]
  1000   C3538851:HIP [Gene or Genome]

Phrase: "His-Leu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.159: Both the enzymatically inactive E362D/E960D and the wtACE protein incubated with 1 M captopril produced no detectable degradation product (Fig. 4C). 

Phrase: "Both"

Phrase: "the enzymatically inactive E362D/E960D"

Phrase: "and"

Phrase: "the wtACE protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "incubated with 1 M captopril"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "produced"

Phrase: "no detectable degradation product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.160: View larger version (30K): [in this window] [in a new window]  FIGURE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 3."
Processing 00000000.tx.161: Transfected human ACE promotes clearance and secondary degradation of cell-derived human A40 and A42. 

Phrase: "Transfected human ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "secondary degradation of cell-derived human A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "A42."
Processing 00000000.tx.162: HEK293 cells stably transfected with human APP695 bearing the AD-causing Swedish mutation were transiently transfected with empty vector, the well characterized A-degrading protease IDE, or ACE. 

Phrase: "HEK293 cells stably"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   876   C0427861:Human cells [Laboratory or Test Result]
   841   C1947950:Embryonic Cell [Embryonic Structure]
   822   C0553257:kidney cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with human APP695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086418:Human [Human]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the AD-"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "Swedish mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with empty vector,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1880497:Empty [Qualitative Concept]
   715 E C0333668:Depleted [Functional Concept]

Phrase: "the well characterized A-degrading protease IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   835   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   835   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   793   C0014442:Enzyme [Enzyme,Organic Chemical]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C0014445:enzymes [Functional Concept]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "ACE."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.163: Media were conditioned on the cells for 18 h, and their A levels were determined by ELISA specific to intact A species beginning at residue 1 and ending at either residue 40 (solid bars)or 42 (hatched bars) (A) or ELISA specific to the middle region of the A peptide (residues 13-28, denoted as X) and either residue 40 (solid bars) or 42 (hatched bars) (B). 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "conditioned on the cells"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0009647:Conditioned [Mental Process]
   770   C3282337:Cells [Cell]
   737 E C0012634:condition [Disease or Syndrome]
   737 E C0348080:Condition [Qualitative Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1705253:Condition [Conceptual Entity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "for 18 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "their A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0014441:ELISA [Laboratory Procedure]

Phrase: "specific to intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "beginning at residue 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439659:Beginning [Temporal Concept]
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "ending at either residue 40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444930:ending [Spatial Concept]
   760   C2746065:Ending [Temporal Concept]

Phrase: "(solid bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "42"

Phrase: "(hatched bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "(A)"

Phrase: "or"

Phrase: "ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "specific to the middle region of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(residues 13-28,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "denoted as X)"

Phrase: "and"

Phrase: "either residue 40"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "(solid bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "42"

Phrase: "(hatched bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.164: Data represent the means  S.E. of 6-8 independent experiments measured in duplicate. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of 6-8 independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "measured in duplicate."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0205173:Duplicate [Functional Concept]
   790   C0444706:Measured [Qualitative Concept]
   790   C3539942:Duplicate [Intellectual Product]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.165: Values were normalized to empty vector to allow combination of data sets, compared with empty vector (*, p < 0.05; **, p < 0.01; ***, p < 0.001). 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "normalized to empty vector to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1880497:Empty [Qualitative Concept]
   760   C1882115:Normalized [Research Activity]
   704 E C0333668:Depleted [Functional Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "combination of data sets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "compared with empty vector"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1707455:Compared [Activity]
   770   C1880497:Empty [Qualitative Concept]
   715 E C0333668:Depleted [Functional Concept]

Phrase: "("

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.166: C, immunoblots of transient transfections into HEK293 cells. 

Phrase: "C,"

Phrase: "immunoblots of transient transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "into HEK293 cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   897   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   836   C0553257:kidney cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.167: ACE and IDE panels indicate total cellular expression of the protein, whereas the HA-IDE panel indicates expression of the tagged IDE construct only. 

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "IDE panels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "indicate"

Phrase: "total cellular expression of the protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "whereas"

Phrase: "the HA-IDE panel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0441833:Panel [Idea or Concept]
   804   C1999270:Panel [Intellectual Product]
   804   C3537156:Panel [Manufactured Object]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "indicates"

Phrase: "expression of the tagged IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "only."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]
Processing 00000000.tx.168: Each immunoblot is representative of at least four independent experiments.  

Phrase: "Each immunoblot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "is"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least four independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.169: Both the N- and C-domains of ACE Promote A DegradationTo determine the effects of each ACE active site on A levels, conditioned medium from each doubly stable line was analyzed for total A content by ELISA. 

Phrase: "Both"

Phrase: "the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-domains of ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "Promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "A DegradationTo"

Phrase: "determine"

Phrase: "the effects of each ACE active site"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "on A levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "conditioned medium from each doubly stable line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   748   C0009458:Medium [Intellectual Product]
   748   C0439536:Medium [Quantitative Concept]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "analyzed for total"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439175:% total [Quantitative Concept]
   790   C0439810:Total [Qualitative Concept]
   790   C0936012:Analyzed [Research Activity]

Phrase: "A content by ELISA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.170: Normalizing A values of the APP + empty vector condition to APP content, there was no significant difference in A levels between APP + empty vector and the catalytically inactive APP + E362D/E960D. 

Phrase: "Normalizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882115:Normalize [Research Activity]

Phrase: "A values of the APP + empty vector condition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0042295:Values [Qualitative Concept]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "to APP content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in A levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between APP + empty vector"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]
   827   C1880497:Empty [Qualitative Concept]
   771 E C0333668:Depleted [Functional Concept]
   743 E C1550032:Unload [Idea or Concept]
   743 E C1996907:Emptying [Activity]

Phrase: "and"

Phrase: "the catalytically inactive APP + E362D/E960D."
Processing 00000000.tx.171: The N- and C-catalytic domains of ACE were each found to decrease cell-derived A levels to a quantitatively similar degree as wtACE. 

Phrase: "The N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-catalytic domains of ACE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0600499:Domains, Catalytic [Amino Acid Sequence]
   714   C1880389:Domain [Functional Concept]
   714   C1883221:Domain [Conceptual Entity]
   714   C3541951:Domain [Intellectual Product]

Phrase: "were"

Phrase: "each"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "cell-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "A levels to a quantitatively similar degree"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "as wtACE."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.172: E362D reduced A levels to 52%, E960D to 43%, and wtACE to 34% of the APP + empty vector condition (Fig. 4D). 

Phrase: "E362D"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "A levels to 52%,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "E960D to 43%,"

Phrase: "and"

Phrase: "wtACE to 34% of the APP + empty vector condition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1883559:Wild Type [Organism Attribute]
   738   C0332307:Type [Qualitative Concept]
   738   C0445392:Wild [Intellectual Product]
   738   C1547052:*Type [Quantitative Concept]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.173: Both single mutants and the wtACE enzymes were significantly different from APP + empty vector (p < 0.001) but not significantly different from each other. 

Phrase: "Both single mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "the wtACE enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]

Phrase: "were"

Phrase: "significantly different from APP + empty vector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "but"

Phrase: "not significantly different from each other."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.174: These differences in A content could not be ascribed to the ACE enzyme altering the levels of the - or -secretase-generated APP C-terminal fragments, since both C99 and C83 were not significantly changed compared with APP + empty vector (Fig. 4A, bottom panel). 

Phrase: "These differences in A content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "ascribed to the ACE enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of the - or -secretase-generated APP C-terminal fragments,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   818   C1707271:C-Terminal [Amino Acid Sequence]
   795   C0205088:Terminal [Temporal Concept]
   795   C0332255:fragments [Functional Concept]
   795   C0486805:Fragments [Body Substance]
   795   C1705314:Terminal [Manufactured Object]
   795   C1705315:Terminal [Spatial Concept]
   762 E C1708096:Fragment [Qualitative Concept]

Phrase: "since"

Phrase: "both C99"

Phrase: "and"

Phrase: "C83"

Phrase: "were"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "compared with APP + empty vector"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   760   C1880497:Empty [Qualitative Concept]
   760   C3538722:APP [Laboratory Procedure]
   704 E C0333668:Depleted [Functional Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.175: Thus, using conservative mutations to inactivate the ACE catalytic domains, these experiments demonstrate that both the N- and C-domains are capable of mediating clearance of naturally produced, cell-derived A in intact cells. 

Phrase: "Thus,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "conservative mutations to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "inactivate"

Phrase: "the ACE catalytic domains,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0600499:Domains, Catalytic [Amino Acid Sequence]
   771   C1880389:Domain [Functional Concept]
   771   C1883221:Domain [Conceptual Entity]
   771   C3541951:Domain [Intellectual Product]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "both the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "capable of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C2698977:Capability [Qualitative Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "clearance of naturally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449297:Clearance [Qualitative Concept]
   790   C1382187:Clearance [Clinical Attribute]
   790   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "produced"

Phrase: ","

Phrase: "cell-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "A in intact cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   816   C0682538:intact cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0205266:Intact [Qualitative Concept]
   770   C1554187:Intact [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.176: A Levels Are Increased by ACE InhibitionTo determine whether decreasing ACE activity with a small molecule inhibitor could elevate cell-derived A levels, we preincubated cells for 24 h in the presence of the prototypical ACE inhibitor, captopril, and then conditioned the media for 18 h in the presence of the drug. 

Phrase: "A Levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "Are"

Phrase: "Increased by ACE InhibitionTo"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "decreasing ACE activity with a small molecule inhibitor"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   817   C1152583:angiotensin-converting enzyme inhibitor activity [Molecular Function]
   806   C2258685:angiotensin converting enzyme activity [Molecular Function]
   799   C0003015:Angiotensin-converting enzyme inhibitor [Pharmacologic Substance]
   799   C2757044:Angiotensin Converting Enzyme Inhibitor [Molecular Function]
   799   C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   782   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   775   C1152555:enzyme inhibitor activity [Molecular Function]
   760   C0243102:enzyme activity [Molecular Function]
   757   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   757   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   739   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "could"

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "cell-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "A levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "we"

Phrase: "preincubated"

Phrase: "cells for 24 h"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the prototypical ACE inhibitor,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   937   C0003015:Angiotensin-converting enzyme inhibitor [Pharmacologic Substance]
   937   C2757044:Angiotensin Converting Enzyme Inhibitor [Molecular Function]
   937   C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   840   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   840   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C1999216:Inhibitor [Qualitative Concept]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "captopril,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "conditioned"
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
  1000   C0009647:Conditioned [Mental Process]
   966 E C0012634:condition [Disease or Syndrome]
   966 E C0348080:Condition [Qualitative Concept]
   966 E C1705253:Condition [Conceptual Entity]
   928 E C0040607:Training [Educational Activity]
   928 E C0220931:Training [Educational Activity]
   928 E C0336809:Train [Manufactured Object]
   928 E C1552514:Train [Manufactured Object]
   928 E C2673163:training [Qualitative Concept]

Phrase: "the media for 18 h"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the drug."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.177: Increasing doses of captopril were tested, and the resulting conditioned media were analyzed by ELISA for total A content. 

Phrase: "Increasing doses of captopril"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0178602:Doses [Quantitative Concept]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the resulting conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "analyzed by ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "for total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "A content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.178: A values were normalized to those of the same cell line with no drug treatment. 

Phrase: "A values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "normalized to those of the same cell line"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0007600:Cell Line [Cell]
   744   C0007634:Cell [Cell]
   744   C0205132:Line [Spatial Concept]
   744   C0445247:Same [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1882115:Normalized [Research Activity]
   744   C1948049:Cell [Spatial Concept]

Phrase: "with no drug treatment."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1254351:Drug [Pharmacologic Substance]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.179: Captopril was found to have no significant effect on A levels in the catalytically inactive APP + E362D/E960D cell line, as expected. 

Phrase: "Captopril"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "no significant effect on A levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in the catalytically inactive APP + E362D/E960D cell line,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   818   C0007600:Cell Line [Cell]
   795   C0007634:Cell [Cell]
   795   C0205132:Line [Spatial Concept]
   795   C1269647:Cell [Cell]
   795   C1550648:Line [Substance]
   795   C1552960:Line [Quantitative Concept]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "expected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.180: In contrast, the captopril-treated APP + wtACE cells accumulated nearly 2-fold more A than untreated cells at drug concentrations above 1 M (p < 0.01). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the captopril-treated APP + wtACE cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   813   C0449475:type cell [Intellectual Product]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "accumulated"

Phrase: "nearly 2-fold more"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "A than untreated cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0332155:untreated [Finding]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "at drug concentrations"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   966   C0678756:drug concentration [Quantitative Concept]
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0086045:Concentrations [Mental Process]
   861   C1254351:Drug [Pharmacologic Substance]
   827 E C1446561:Concentration [Quantitative Concept]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "above 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M ("

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.181: At 0.1 M captopril, the lowest concentration tested, A levels were elevated 1.5-fold in APP + wtACE cells compared with the same cell line without drug (p < 0.05). 

Phrase: "At 0.1 M captopril,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "the lowest concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "1.5-fold in APP + wtACE cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332462:Fold [Spatial Concept]
   742   C1880834:FOLD [Phenomenon or Process]

Phrase: "compared with the same cell line"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0007600:Cell Line [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:Line [Spatial Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1707455:Compared [Activity]
   753   C1948049:Cell [Spatial Concept]

Phrase: "without drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "(p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.182: These results demonstrate that a widely prescribed ACE inhibitor can promote accumulation of natural, cell-derived A by blocking ACE proteolytic activity.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "a widely prescribed ACE inhibitor"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0003015:Angiotensin-converting enzyme inhibitor [Pharmacologic Substance]
   901   C2757044:Angiotensin Converting Enzyme Inhibitor [Molecular Function]
   901   C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   861   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   827   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   799   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C1999216:Inhibitor [Qualitative Concept]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "can"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "accumulation of natural, cell-"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "A by blocking ACE proteolytic activity."
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   822   C2258685:angiotensin converting enzyme activity [Molecular Function]
   800   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   767   C0030940:Proteolytic enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0243102:enzyme activity [Molecular Function]
   767   C1947941:Proteolytic Enzyme [Enzyme]
           proteolytic
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0205177:Activity [Functional Concept]
   744   C0233660:Blocking [Mental or Behavioral Dysfunction]
   744   C0332206:Blocking [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0597304:Proteolytic [Molecular Function]
   744   C1561536:*Activity [Idea or Concept]
   711 E C0028778:Block [Pathologic Function]
   711 E C1533157:Block [Substance]
   711 E C1706084:Block [Geographic Area]
   711 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.183: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Our experiments demonstrate that ACE expression leads to cleavage of the amyloid -protein in a cellular context and that ACE promotes the degradation of both naturally produced A40 and A42. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that ACE expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "leads to cleavage of the amyloid -protein"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0010813:cleavage [Cell Function]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0181586:leads [Medical Device]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1330957:cleavage [Cell Function]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in a cellular context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449255:Context [Finding]
   861   C0542559:Context [Functional Concept]

Phrase: "and"

Phrase: "that ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the degradation of both naturally produced A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "A42."
Processing 00000000.tx.184: Investigating the role of the N- and C-domains of ACE in A clearance by site-directed mutagenesis, we used a conservative but inactivating mutation of the ACE metalloprotease active site and found that both domains are responsible for A clearance. 

Phrase: "Investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "the role of the N-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "C-domains of ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "in A clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "by site-directed mutagenesis,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a conservative"

Phrase: "but"

Phrase: "inactivating mutation of the ACE metalloprotease active site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0026882:Mutation [Genetic Function]
   739   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "both domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1880389:Domain [Functional Concept]
   966   C1883221:Domain [Conceptual Entity]
   966   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "responsible for A clearance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.185: Our data do not support a role for the putative signal transduction mechanism of ACE (18) in its lowering of A, since overexpressing the proteolytically inactive form of ACE produced no change in A levels compared with vector alone. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a role for the putative signal transduction mechanism of ACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0035820:Role [Social Behavior]
   736   C1705810:Role [Conceptual Entity]

Phrase: "(18"

Phrase: ")"

Phrase: "in its lowering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441994:lowering [Spatial Concept]
  1000   C2003888:Lowering [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "of A,"

Phrase: "since"

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the proteolytically inactive form of ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "produced"

Phrase: "no change in A levels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442739:No change [Finding]
   806   C1548568:No change [Intellectual Product]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "compared with vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0442335:Vector [Spatial Concept]
   790   C1705099:Vector [Idea or Concept]
   790   C1707455:Compared [Activity]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.186: Finally, we show that captopril, a widely prescribed ACE inhibitor, promotes A accumulation in the media of cells expressing human APP and ACE. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that captopril,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "a widely prescribed ACE inhibitor,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0003015:Angiotensin-converting enzyme inhibitor [Pharmacologic Substance]
   901   C2757044:Angiotensin Converting Enzyme Inhibitor [Molecular Function]
   901   C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   861   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   827   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   799   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C1999216:Inhibitor [Qualitative Concept]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "A accumulation in the media of cells"

Phrase: "expressing"

Phrase: "human APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "ACE."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.187: It has been reported recently that the N-domain of ACE, but not its C-domain, is responsible for the degradation of synthetic A40 in vitro (40). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that"

Phrase: "the N-domain of ACE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "its C-domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "responsible for the degradation of synthetic A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.188: In that study, the ACE catalytic domains were cloned in isolation, producing recombinant truncation proteins bearing one ACE active site. 

Phrase: "In"

Phrase: "that study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the ACE catalytic domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0600499:Domains, Catalytic [Amino Acid Sequence]
   771   C1880389:Domain [Functional Concept]
   771   C1883221:Domain [Conceptual Entity]
   771   C3541951:Domain [Intellectual Product]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "were"

Phrase: "cloned in isolation,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0009013:cloned [Cell]
   790   C0204727:Isolation [Therapeutic or Preventive Procedure]
   790   C0205409:Isolation [Functional Concept]
   790   C0220862:isolation [Laboratory Procedure]
   756 E C1522642:Clone [Tissue]
   718 E C1548221:Isolated [Idea or Concept]

Phrase: "producing"

Phrase: "recombinant truncation proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "one ACE active site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205681:Active Site [Functional Concept]
   799   C0205145:Site [Spatial Concept]
   799   C0205177:Active [Functional Concept]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]
Processing 00000000.tx.189: In contrast, we find that both the N- and C-domains of ACE are able to degrade naturally produced A in a cellular context. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that"

Phrase: "both the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-domains of ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "degrade"

Phrase: "naturally"

Phrase: "produced"

Phrase: "A in a cellular context."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0449255:Context [Finding]
   760   C0542559:Context [Functional Concept]
Processing 00000000.tx.190: In our studies, we used conservative mutations to inactivate each catalytic domain in the same molecule, conserving the overall structure and sequence of the full-length protein. 

Phrase: "In our studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "conservative mutations to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "inactivate"

Phrase: "each catalytic domain in the same molecule,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0600499:Catalytic Domain [Amino Acid Sequence]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
   738   C0599845:molecular domain [Molecular Function]

Phrase: "conserving"

Phrase: "the overall structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "sequence of the full-length protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0002518:Protein Sequence [Amino Acid Sequence]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.191: It is possible that the C-domain is only able to degrade A in intact cells, not in vitro. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the C-domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "only able to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0085732:Able [Organism Attribute]
   827   C0205171:Only [Quantitative Concept]
   827   C1299581:Able [Finding]
   827   C1720467:Only [Intellectual Product]

Phrase: "degrade"

Phrase: "A in intact cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   816   C0682538:intact cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0205266:Intact [Qualitative Concept]
   770   C1554187:Intact [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "not in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.192: There is evidence that each catalytic domain of ACE regulates the activity of the other (41), suggesting that the full-length protein is required for normal substrate recognition and degradation. 

Phrase: "There"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "each catalytic domain of ACE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0600499:Catalytic Domain [Amino Acid Sequence]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "regulates"

Phrase: "the activity of the"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "other"

Phrase: "(41"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the full-length protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "required for normal substrate recognition"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0524637:Recognition [Mental Process]
   760   C1514873:Required [Functional Concept]
   760   C1710236:Substrate [Manufactured Object]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.193: The C-domain, when expressed outside of the context of the full-length enzyme, may not retain the tertiary structure required to degrade larger substrates such as A, whereas much smaller substrates are still processed (40). 

Phrase: "The C-domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "when"

Phrase: "expressed outside of the context of the full-length enzyme,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0205101:Outside [Spatial Concept]
   739   C0443225:Full [Qualitative Concept]
   739   C0449255:Context [Finding]
   739   C0542559:Context [Functional Concept]
   739   C1444754:Length [Quantitative Concept]
   739   C1706316:LENGTH [Research Activity]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "the tertiary structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205372:Tertiary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "larger substrates such as A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710236:Substrate [Manufactured Object]

Phrase: "whereas"

Phrase: "much smaller substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "are"

Phrase: "still"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.194: It is unlikely that incomplete inactivation of the N-domain in our E362D mutant enzyme could account for the observed decrease in A, because when both domains are inactivated in the E362D/E960D ACE construct, we observe no change in A levels compared with the empty vector control. 

Phrase: "It"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that incomplete inactivation of the N-domain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "in our E362D mutant enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "could"

Phrase: "account for the observed decrease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]

Phrase: "in A,"

Phrase: "because"

Phrase: "when"

Phrase: "both domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1880389:Domain [Functional Concept]
   966   C1883221:Domain [Conceptual Entity]
   966   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "inactivated in the E362D/E960D ACE construct,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   742   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C2827421:Construct [Classification]

Phrase: "we"

Phrase: "observe"

Phrase: "no change in A levels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442739:No change [Finding]
   806   C1548568:No change [Intellectual Product]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "compared with the empty vector control."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0031249:vector control [Occupational Activity]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243148:control [Qualitative Concept]
   753   C0442335:Vector [Spatial Concept]
   753   C1550141:Control [Substance]
   753   C1705099:Vector [Idea or Concept]
   753   C1707455:Compared [Activity]
   753   C1880497:Empty [Qualitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.195: View larger version (41K): [in this window] [in a new window]  FIGURE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 4."
Processing 00000000.tx.196: Cell-derived A is degraded by both the N- and C-domains of ACE and elevated by ACE inhibition. 

Phrase: "Cell-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "A"

Phrase: "is"

Phrase: "degraded by both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-domains of ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "elevated by ACE inhibition."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   790   C0877008:enzyme inhibition [Disease or Syndrome]
   790   C1524081:Enzyme Inhibition [Physiologic Function]
   783   C0743534:elevated enzyme [Finding]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0205250:Elevated [Qualitative Concept]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3163633:Elevated [Qualitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.197: CHO cells were stably transfected with both human APP751 bearing the V717F AD-causing missense mutation and either empty vector, human wild-type ACE, or the indicated ACE mutant constructs. 

Phrase: "CHO cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with both human APP751"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086418:Human [Human]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the V717F AD-causing missense mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C2985434:Disease-causing Mutation [Cell or Molecular Dysfunction]
   827   C0599155:Missense Mutation [Genetic Function]
   799   C0026882:Mutation [Genetic Function]
   799   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "either empty vector,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "human wild-type ACE,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   799   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "or"

Phrase: "the indicated ACE mutant constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C2827421:Construct [Classification]
Processing 00000000.tx.198: A, immunoblots showing expression of ACE, APP, and APP C-terminal fragments in the stable cell lines. 

Phrase: "A,"

Phrase: "immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "expression of ACE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "APP C-terminal fragments in the stable cell lines."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C1707271:C-Terminal [Amino Acid Sequence]
   742   C0205088:Terminal [Temporal Concept]
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   708 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.199: Note the slightly higher expression of human APP (hAPP) in the APP + empty vector line, resulting presumably from modest cytomegalovirus promoter competition between the APP and ACE constructs. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the slightly higher expression of human APP (hAPP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the APP + empty vector line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "resulting"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0678226:resulting [Functional Concept]
   966 E C1274040:Result [Functional Concept]
   966 E C1546471:Result [Idea or Concept]
   966 E C2825142:Result [Finding]

Phrase: "presumably from modest cytomegalovirus promoter competition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010825:Cytomegalovirus [Virus]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0679932:competition [Social Behavior]

Phrase: "between the APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "ACE constructs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C2827421:Construct [Classification]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
Processing 00000000.tx.200: Immunoblots are representative of at least four independent determinations. 

Phrase: "Immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least four independent determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0680730:determinations [Governmental or Regulatory Activity]
   779 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.201: B, conditioned medium of the stable lines was concentrated and probed for the presence of secreted ACE (sACE) protein. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "conditioned medium of the stable lines"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "concentrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]

Phrase: "and"

Phrase: "probed for the presence of secreted ACE"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   742   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C1327616:Secreted [Cell Function]
   708   C0182400:Probe [Medical Device]
   708   C1704681:Probe [Gene or Genome]
   708   C2347609:Probe [Chemical Viewed Functionally]
   708   C3536729:Probe [Manufactured Object]

Phrase: "(sACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: ")"

Phrase: "protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.202: C, ACE activity assay incubating 2.5 g of cell lysate with 1 mM Hip-His-Leu for the indicated time points at 37 C. 

Phrase: "C,"

Phrase: "ACE activity assay"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C2717977:Enzyme Assay [Laboratory Procedure]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
   771   C2258685:angiotensin converting enzyme activity [Molecular Function]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:incubating [Laboratory Procedure]

Phrase: "2.5 g of cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0524983:G cell [Cell]
   753   C0439267:g% [Quantitative Concept]

Phrase: "with 1 mM Hip-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0019552:Hip [Body Part, Organ, or Organ Component]
   827   C0022122:Hip [Body Part, Organ, or Organ Component]
   827   C3538851:HIP [Gene or Genome]

Phrase: "His-Leu for the indicated time points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0062762:His-Leu [Amino Acid, Peptide, or Protein]
   748   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "at 37 C."
Processing 00000000.tx.203: Values represent the means  S.E. obtained from 3-5 independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "obtained from 3-5 independent experiments."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0085862:Independent [Idea or Concept]
   753   C0681814:Experiments [Research Activity]
   753   C1299583:Independent [Finding]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706386:Experiment [Conceptual Entity]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.204: D, cell lines were conditioned for 18 h, and the media were harvested and probed by ELISA for total A content. 

Phrase: "D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "conditioned for 18 h,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0009647:Conditioned [Mental Process]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737 E C0012634:condition [Disease or Syndrome]
   737 E C0348080:Condition [Qualitative Concept]
   737 E C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "probed by ELISA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0014441:ELISA [Laboratory Procedure]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "for total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "A content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.205: Due to elevated APP expression, A values in the APP + empty vector condition were normalized by APP expression to the APP and ACE doubly stable lines. 

Phrase: "Due to elevated APP expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "A values in the APP + empty vector condition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0042295:Values [Qualitative Concept]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "normalized by APP expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C1882115:Normalized [Research Activity]
   770   C3538722:APP [Laboratory Procedure]

Phrase: "to the APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "ACE doubly stable lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0205132:lines [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.206: Data represent the means  S.E. of seven independent experiments measured in duplicate. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of seven independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "measured in duplicate."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0205173:Duplicate [Functional Concept]
   790   C0444706:Measured [Qualitative Concept]
   790   C3539942:Duplicate [Intellectual Product]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.207: Values were normalized to APP + empty vector to allow the combination of data sets; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "normalized to APP + empty vector to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1880497:Empty [Qualitative Concept]
   753   C1882115:Normalized [Research Activity]
   753   C3538722:APP [Laboratory Procedure]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the combination of data sets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: ";"
Processing 00000000.tx.208: ***, p < 0.001, compared with empty vector. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with empty vector."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1707455:Compared [Activity]
   770   C1880497:Empty [Qualitative Concept]
   715 E C0333668:Depleted [Functional Concept]
Processing 00000000.tx.209: E, fold change in A content of conditioned medium of APP + wtACE and APP + E362D/E960D cell lines after 24-h pretreatment and 18-h conditioning in the presence of captopril. 

Phrase: "E,"

Phrase: "fold change in A content of conditioned medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1880833:Fold Change [Quantitative Concept]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "of APP + wtACE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1883559:Wild Type [Organism Attribute]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "APP + E362D/E960D cell lines after 24-h pretreatment"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C0007600:Cell lines [Cell]
   742   C0007634:Cell [Cell]
   742   C0205132:lines [Spatial Concept]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   708 E C1550648:Line [Substance]
   708 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "18-h conditioning in the presence of captopril."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0009647:Conditioning [Mental Process]
Processing 00000000.tx.210: Each data point was normalized to untreated cells (0 M captopril) of the same doubly transfected cell line. 

Phrase: "Each data point"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1511726:Data Point [Idea or Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "was"

Phrase: "normalized to untreated cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0332155:untreated [Finding]
   770   C1882115:Normalized [Research Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(0 M captopril"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "of the same doubly transfected cell line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.211: Data represent the means  S.E. of four independent experiments measured in duplicate; 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of four independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "measured in duplicate"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0205173:Duplicate [Functional Concept]
   790   C0444706:Measured [Qualitative Concept]
   790   C3539942:Duplicate [Intellectual Product]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: ";"
Processing 00000000.tx.212: ACE compared with E362D/E960D at each dose: *, p < 0.05; 

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "compared with E362D/E960D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "at each dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: ":"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.213: **, p < 0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.214: ***, p < 0.001.  

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.215: Growing genetic evidence suggests ACE as a potential risk factor for AD. 

Phrase: "Growing"

Phrase: "genetic evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "ACE as a potential risk factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "for AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.216: At this writing, approximately 40 published studies have examined this relationship, with the majority finding a significant association of ACE genotype to AD. 

Phrase: "At this writing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043266:Writing [Occupation or Discipline]
  1000   C2584304:Writing [Mental Process]

Phrase: "approximately 40 published studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "this relationship,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "with the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "a significant association of ACE genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "to AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.217: Further, post-mortem analysis of AD brain tissue has shown significant elevation of ACE protein compared with control (28), perhaps representing an up-regulation of an A clearance mechanism. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "post-mortem analysis of AD brain tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant elevation of ACE protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "perhaps"

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "an up-regulation of an"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "A clearance mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.218: Interestingly, initiation of ACE-mediated signal transduction by its substrates has been shown to up-regulate the enzyme's own expression via the c-Jun N-terminal kinase pathway (18, 42). 

Phrase: "Interestingly,"

Phrase: "initiation of ACE-mediated signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0589507:Initiation [Mental Process]
   744   C1158830:Initiation [Genetic Function]
   744   C1704686:Initiation [Functional Concept]

Phrase: "by its substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "up-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "the enzyme's own expression via the c-Jun N-terminal kinase pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(18,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.219: This feedback system provides a hypothetical mechanism by which ACE could modulate its own expression depending on levels of the A substrate, leading to elevated levels of ACE in AD cortex. 

Phrase: "This feedback system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0015744:Feedback [Phenomenon or Process]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   861   C2911691:Feedback [Mental Process]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a hypothetical mechanism by which ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0596524:enzyme mechanism [Molecular Function]
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "could"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "its own expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "depending on levels of the"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726   C0725813:depend [Medical Device]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "A substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "leading to elevated levels of ACE"
Meta Candidates (Total=21; Excluded=8; Pruned=0; Remaining=13)
   800   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   767   C0014440:enzyme levels [Laboratory Procedure]
   767   C0743534:elevated enzyme [Finding]
   767   C1287349:enzyme levels [Laboratory or Test Result]
   767   C1318746:Elevated lead level [Finding]
   750   C0428255:lead levels [Laboratory or Test Result]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0205250:Elevated [Qualitative Concept]
   744   C0332152:Leading [Temporal Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1522538:Leading [Functional Concept]
   744   C3163633:Elevated [Qualitative Concept]
   734 E C0524167:Lead level [Laboratory Procedure]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C0456079:Level [Classification]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1547707:Level [Geographic Area]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C2946261:Level [Pharmacologic Substance]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in AD cortex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.220: Our observation that ACE inhibition in cells expressing both human APP and ACE promotes accumulation of secreted A may bear clinical relevance. 

Phrase: "Our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that ACE inhibition in cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0877008:enzyme inhibition [Disease or Syndrome]
   778   C1524081:Enzyme Inhibition [Physiologic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "expressing"

Phrase: "both human APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "accumulation of secreted A"

Phrase: "may"

Phrase: "bear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "clinical relevance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevance [Qualitative Concept]
Processing 00000000.tx.221: Given that neurons produce both APP and ACE and neuronal ACE is up-regulated in AD (27), we hypothesize that chronic pharmacological inhibition of ACE could increase levels of brain A by reducing ACE-dependent proteolysis. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "produce"

Phrase: "both APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "neuronal ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "up-regulated in AD"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "hypothesize"

Phrase: "that chronic pharmacological inhibition of ACE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0877008:enzyme inhibition [Disease or Syndrome]
   767   C1524081:Enzyme Inhibition [Physiologic Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "could"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "levels of brain A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "by reducing ACE-dependent proteolysis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0597304:Proteolysis [Molecular Function]
   727 E C1947941:proteolytic [Enzyme]
Processing 00000000.tx.222: No studies have yet examined the consequence of chronic ACE inhibition on levels of brain or plasma A in humans. 

Phrase: "No studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "yet"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the consequence of chronic ACE inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "on levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "plasma A in humans."
Processing 00000000.tx.223: Very few clinical trials of ACE inhibitors have analyzed their effects on cognitive decline in AD subjects, and results to date are inconclusive (43-45). 

Phrase: "Very few clinical trials of ACE inhibitors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0008976:Clinical Trials [Research Activity]
           Trial
   764   C1096775:clinical trials [Intellectual Product]
   742   C0205210:Clinical [Qualitative Concept]

Phrase: "have"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "their effects on cognitive decline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in AD subjects,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "and"

Phrase: "results to date"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0011008:Date [Temporal Concept]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2348077:Date [Food]
   790   C2825142:Result [Finding]

Phrase: "are"

Phrase: "inconclusive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205258:Inconclusive [Idea or Concept]
  1000   C1629507:Inconclusive [Qualitative Concept]

Phrase: "(43-45"

Phrase: ")."
Processing 00000000.tx.224: No studies on the effects of ACE deficiency or overexpression on A metabolism in vivo have been reported. 

Phrase: "No studies on the effects of ACE deficiency"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C0947630:studies [Laboratory Procedure]
   706 E C0557651:Study [Manufactured Object]
   706 E C2603343:Study [Research Activity]

Phrase: "or"

Phrase: "overexpression on A metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "have"

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.225: Such studies may be problematic in interpretation, because endogenous murine A has amino acid differences from the human peptide immediately surrounding the putative site of cleavage by ACE, and these could affect its properties as a substrate. 

Phrase: "Such studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "problematic in interpretation,"

Phrase: "because"

Phrase: "endogenous murine A"

Phrase: "has"

Phrase: "amino acid differences from the human peptide immediately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the putative site of cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "by ACE,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "these"

Phrase: "could"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "its properties as a substrate."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]
Processing 00000000.tx.226: Future in vivo studies that examine ACE inhibition, deficiency, or overexpression in mice expressing human APP may be most instructive regarding the role of ACE in Alzheimer disease. 

Phrase: "Future"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016884:Future [Temporal Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "examine"

Phrase: "ACE inhibition,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0877008:enzyme inhibition [Disease or Syndrome]
   861   C1524081:Enzyme Inhibition [Physiologic Function]
   812   C0021467:Inhibition [Mental Process]
   812   C0021469:Inhibition [Molecular Function]
   812   C1628982:% inhibition [Quantitative Concept]
   812   C3463820:Inhibition [Activity]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   741 E C0311403:Inhibited [Qualitative Concept]

Phrase: "deficiency,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011155:Deficiency [Functional Concept]
  1000   C0162429:Deficiency [Disease or Syndrome]
  1000   C1623416:deficiency [Qualitative Concept]
   928 E C1636779:% deficient [Quantitative Concept]

Phrase: "or"

Phrase: "overexpression in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "expressing"

Phrase: "human APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538722:APP [Laboratory Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "most instructive regarding"

Phrase: "the role of ACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.227: In the context of our new findings and the earlier studies reviewed above, we hypothesize that decreased activity of ACE in the aged human brain, originating either from genetic polymorphisms or pharmacological inhibition, may promote A accumulation and thus modulate the likelihood of the development of Alzheimer disease and/or its neuropathological severity. 

Phrase: "In the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of our new findings"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C1268649:New finding [Finding]
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "the earlier studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "above,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "we"

Phrase: "hypothesize"

Phrase: "that decreased activity of ACE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C2258685:angiotensin converting enzyme activity [Molecular Function]
   778   C0086439:Decreased activity [Sign or Symptom]
   774   C0243102:enzyme activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in the aged human brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "originating"

Phrase: "either from genetic polymorphisms"
Meta Candidates (Total=12; Excluded=8; Pruned=0; Remaining=4)
   833   C0032529:Genetic Polymorphisms [Genetic Function]
           polymorphisms
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   737 E C1882417:Polymorphism [Qualitative Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "or"

Phrase: "pharmacological inhibition,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "A accumulation"

Phrase: "and"

Phrase: "thus"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the likelihood of the development of Alzheimer disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033204:Likelihood [Quantitative Concept]

Phrase: "and/or"

Phrase: "its neuropathological severity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0439793:Severity [Qualitative Concept]
   861   C2983285:Severity [Intellectual Product]
   789 E C0205082:Severe [Qualitative Concept]
Processing 00000000.tx.228: Our findings suggest the need for further analyses of the biological effects of ACE genetic deficiency and ACE pharmacological inhibition, both in experimental models of AD and in the large human population currently experiencing chronic ACE inhibition.  

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the need for further analyses of the biological effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0027552:Need [Qualitative Concept]
   742   C0686904:need [Functional Concept]

Phrase: "of ACE genetic deficiency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   853   C0149676:Enzyme Deficiency [Disease or Syndrome]
   804   C0011155:Deficiency [Functional Concept]
   804   C0162429:Deficiency [Disease or Syndrome]
   804   C1623416:deficiency [Qualitative Concept]
   733 E C1636779:% deficient [Quantitative Concept]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "and"

Phrase: "ACE pharmacological inhibition,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   853   C0877008:enzyme inhibition [Disease or Syndrome]
   853   C1524081:Enzyme Inhibition [Physiologic Function]
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   733 E C0311403:Inhibited [Qualitative Concept]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "both in experimental models of AD"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0086272:Models, Experimental [Intellectual Product]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0683033:disease models [Intellectual Product]
   774   C0684309:disease models [Experimental Model of Disease]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0238767:Both [Spatial Concept]
   748   C1517586:Experimental [Qualitative Concept]
   748   C1706086:Both [Qualitative Concept]
   748   C3161035:Models [Intellectual Product]

Phrase: "and in the large human population currently"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0032659:Population [Quantitative Concept]
   748   C0086418:Human [Human]
   748   C0521116:Currently [Temporal Concept]
   748   C0549177:Large [Quantitative Concept]
   748   C1257890:Population [Population Group]
   748   C1515981:And [Idea or Concept]

Phrase: "experiencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0237607:experience [Mental Process]
   966   C0596545:Experience [Mental Process]

Phrase: "chronic ACE inhibition."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   840   C0877008:enzyme inhibition [Disease or Syndrome]
   840   C1524081:Enzyme Inhibition [Physiologic Function]
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   733 E C0311403:Inhibited [Qualitative Concept]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
Processing 00000000.tx.229: FOOTNOTES  * This work was supported by National Institutes of Health Grant AG12749 (to D. J. S.) and a predoctoral fellowship from the Harvard Center for Neurodegeneration and Repair (to M. L. H.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health Grant AG12749"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018173:Grant [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C1548284:Grant [Idea or Concept]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]

Phrase: "("

Phrase: "to D. J."

Phrase: "S.)"

Phrase: "and"

Phrase: "a predoctoral fellowship from the Harvard Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0015770:Fellowship [Educational Activity]

Phrase: "for Neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "Repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "to M. L. H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.230: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.231: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.232: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.233: 1 To whom correspondence should be addressed: Harvard Institutes of Medicine 730, 77 Ave. 

Phrase: "1 To whom correspondence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282413:Correspondence [Intellectual Product]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Harvard Institutes of Medicine 730,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   851   C0021621:Institute of Medicine [Health Care Related Organization]
           institutes medicine
   760   C0021622:Institutes [Organization]
   726 E C1272753:Institute [Idea or Concept]

Phrase: "77 Ave."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]
Processing 00000000.tx.234: Louis Pasteur, Boston, MA 02115. 

Phrase: "Louis Pasteur,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115."
Processing 00000000.tx.235: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.236: 617-525-5200; 

Phrase: "617-525-5200"

Phrase: ";"
Processing 00000000.tx.237: Fax: 617-525-5252; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "617-525-5252"

Phrase: ";"
Processing 00000000.tx.238: E-mail: dselkoe{at}rics.bwh.harvard.edu . 2 The abbreviations used are: AD, Alzheimer disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "dselkoe{at}rics.bwh.harvard.edu . 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   795   C1837895:RICS [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.239: ACE, angiotensin-converting enzyme; 

Phrase: "ACE,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.240: APP, -amyloid precursor protein; 

Phrase: "APP, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.241: CHO, Chinese hamster ovary; 

Phrase: "CHO,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "Chinese hamster ovary"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.242: HEK293, human embryonic kidney 293; 

Phrase: "HEK293,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0013935:Embryonic [Embryonic Structure]
   812   C0022646:Kidney [Body Part, Organ, or Organ Component]
   812   C0086418:Human [Human]
   812   C0227665:kidney [Body Part, Organ, or Organ Component]
   812   C1278978:Kidney [Body Part, Organ, or Organ Component]
   812   C1514845:KIDNEY [Tissue]
   719 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "human embryonic kidney 293"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0013935:Embryonic [Embryonic Structure]
   812   C0022646:Kidney [Body Part, Organ, or Organ Component]
   812   C0086418:Human [Human]
   812   C0227665:kidney [Body Part, Organ, or Organ Component]
   812   C1278978:Kidney [Body Part, Organ, or Organ Component]
   812   C1514845:KIDNEY [Tissue]
   719 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.243: A, amyloid -protein; 

Phrase: "A,"

Phrase: "amyloid -protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.244: IDE, insulin-degrading enzyme; 

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.245: NEP, neprilysin; 

Phrase: "NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.246: ELISA, enzyme-linked immunosorbant assay; 

Phrase: "ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "enzyme-linked immunosorbant assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0014441:Enzyme-linked immunosorbant assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.247: Hip-His-Leu, hippuryl-L-histidyl-L-leucine; 

Phrase: "Hip-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019552:Hip [Body Part, Organ, or Organ Component]
  1000   C0022122:Hip [Body Part, Organ, or Organ Component]
  1000   C3538851:HIP [Gene or Genome]

Phrase: "His-Leu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "hippuryl-L-histidyl-L-leucine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0062727:hippuryl-L-histidyl-L-leucine [Amino Acid, Peptide, or Protein]
           hippuryl-histidyl-leucine
   804   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.248: I, ACE insertion; 

Phrase: "I,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "ACE insertion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0021107:Insertion [Therapeutic or Preventive Procedure]
   812   C0441587:Insertion [Health Care Activity]
   812   C1512796:Insertion [Genetic Function]
   812   C1883719:Insertion [Functional Concept]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.249: D, ACE deletion; 

Phrase: "D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "ACE deletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.250: wtACE, wild-type ACE; 

Phrase: "wtACE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "wild-type ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   721 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.251: HA, hemagglutinin.  

Phrase: "HA,"

Phrase: "hemagglutinin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018909:Haemagglutinin, NOS [Immunologic Factor]
Processing 00000000.tx.252: ACKNOWLEDGMENTS  We thank W. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "W."
Processing 00000000.tx.253: Farris, M. 

Phrase: "Farris,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.254: LaVoie, T. 

Phrase: "LaVoie,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.255: Young, G. 

Phrase: "Young, G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.256: Shankar, B. 

Phrase: "Shankar,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.257: Zheng, and I. 

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]
Processing 00000000.tx.258: Rappley for technical advice and discussions and D. 

Phrase: "Rappley for technical advice"

Phrase: "and"

Phrase: "discussions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557061:discussions [Therapeutic or Preventive Procedure]
   966 E C2584313:Discussion [Social Behavior]

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.259: Walsh for providing the CHO cell line stably transfected with the pFRT/lacZeo vector of the Flp-In system. 

Phrase: "Walsh for providing"

Phrase: "the CHO cell line stably"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   877   C0007600:Cell Line [Cell]
   795   C0205132:Line [Spatial Concept]
   795   C1550648:Line [Substance]
   795   C1552960:Line [Quantitative Concept]

Phrase: "transfected with the pFRT/lacZeo vector of the Flp-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0442335:Vector [Spatial Concept]
   742   C1705099:Vector [Idea or Concept]

Phrase: "In system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.260: We especially thank A. 

Phrase: "We especially"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.261: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.262: Lou, R. 

Phrase: "Lou,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.263: W. 

Phrase: "W."
Processing 00000000.tx.264: Hemming, and N. 

Phrase: "Hemming,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0019080:HEM [Pathologic Function]
   966   C0280599:HEM [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.265: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.266: Hemming for support and encouragement.  

Phrase: "Hemming for support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0019080:HEM [Pathologic Function]
   756   C0280599:HEM [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "encouragement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870494:encouragement [Social Behavior]
Processing 00000000.tx.267: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Gilman, S., Koller, M., Black, R. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Gilman,"

Phrase: "S."

Phrase: ","

Phrase: "Koller,"

Phrase: "M."

Phrase: ","

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.268: S., Jenkins, L., Griffith, S. 

Phrase: "S."

Phrase: ","

Phrase: "Jenkins,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Griffith,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.269: G., Fox, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Fox,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016633:Fox [Mammal]
   928 E C0049564:FOXY [Organic Chemical]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.270: C., Eisner, L., Kirby, L., Rovira, M. 

Phrase: "C., Eisner,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kirby,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Rovira,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.271: B., Forette, F., and Orgogozo, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Forette,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Orgogozo,"

Phrase: "J."
Processing 00000000.tx.272: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.273: (2005) Neurology 64, 1553-1562[Abstract/Free FullText] Selkoe, D. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Neurology 64,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1553-1562"

Phrase: "[Abstract/Free FullText"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.274: J. 

Phrase: "J."
Processing 00000000.tx.275: (2004) Ann. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.276: Intern. 

Phrase: "Intern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1144859:INTERN [Professional or Occupational Group]
Processing 00000000.tx.277: Med. 

Phrase: "Med."
Processing 00000000.tx.278: 140, 627-638[Free FullText] Walsh, D. 

Phrase: "140,"

Phrase: "627-638"

Phrase: "[Free FullText"

Phrase: "] Walsh,"

Phrase: "D."
Processing 00000000.tx.279: M., and Selkoe, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.280: J. 

Phrase: "J."
Processing 00000000.tx.281: (2004) Neuron 44, 181-193[CrossRef][Medline] [OrderarticleviaInfotrieve] Hock, C., Konietzko, U., Streffer, J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neuron 44,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "181-193"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hock,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003086:Hock [Body Location or Region]
  1000   C1522382:Hock [Body Location or Region]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Konietzko,"

Phrase: "U.,"

Phrase: "Streffer,"

Phrase: "J."
Processing 00000000.tx.282: R., Tracy, J., Signorell, A., Muller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., Wollmer, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tracy,"

Phrase: "J.,"

Phrase: "Signorell,"

Phrase: "A.,"

Phrase: "Muller-Tillmanns,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lemke,"

Phrase: "U.,"

Phrase: "Henke,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Moritz,"

Phrase: "E.,"

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "E.,"

Phrase: "Wollmer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.283: A., Umbricht, D., deq Uervain, D. 

Phrase: "A.,"

Phrase: "Umbricht,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "deq Uervain,"

Phrase: "D."
Processing 00000000.tx.284: J., Hofmann, M., Maddalena, A., Papassotiropoulos, A., and Nitsch, R. 

Phrase: "J.,"

Phrase: "Hofmann,"

Phrase: "M."

Phrase: ","

Phrase: "Maddalena,"

Phrase: "A.,"

Phrase: "Papassotiropoulos,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.285: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.286: (2003) Neuron 38, 547-554[CrossRef][Medline] [OrderarticleviaInfotrieve] Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuron 38,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "547-554"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.287: P., Gerard, C., Hama, E., Lee, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gerard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.288: J., and Saido, T. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.289: C. 

Phrase: "C."
Processing 00000000.tx.290: (2001) Science 292, 1550-1552[Abstract/Free FullText] Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 292,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1550-1552"

Phrase: "[Abstract/Free FullText"

Phrase: "] Farris,"

Phrase: "W.,"

Phrase: "Mansourian,"

Phrase: "S."

Phrase: ","

Phrase: "Chang,"

Phrase: "Y.,"

Phrase: "Lindsley,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "E."
Processing 00000000.tx.291: A., Frosch, M. 

Phrase: "A.,"

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.292: P., Eckman, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.293: B., Tanzi, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.294: E., Selkoe, D. 

Phrase: "E.,"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.295: J., and Guenette, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.296: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.297: Natl. 

Phrase: "Natl."
Processing 00000000.tx.298: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.299: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.300: U. 

Phrase: "U."
Processing 00000000.tx.301: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.302: A. 

Phrase: "A."
Processing 00000000.tx.303: 100, 4162-4167[Abstract/Free FullText] Eckman, E. 

Phrase: "100,"

Phrase: "4162-4167"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eckman,"

Phrase: "E."
Processing 00000000.tx.304: A., Watson, M., Marlow, L., Sambamurti, K., and Eckman, C. 

Phrase: "A.,"

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Marlow,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sambamurti,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.305: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.306: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.307: Biol. 

Phrase: "Biol."
Processing 00000000.tx.308: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.309: 278, 2081-2084[Abstract/Free FullText] Tucker, H. 

Phrase: "278,"

Phrase: "2081-2084"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tucker,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.310: M., Kihiko, M., Caldwell, J. 

Phrase: "M."

Phrase: ","

Phrase: "Kihiko,"

Phrase: "M."

Phrase: ","

Phrase: "Caldwell,"

Phrase: "J."
Processing 00000000.tx.311: N., Wright, S., Kawarabayashi, T., Price, D., Walker, D., Scheff, S., McGillis, J. 

Phrase: "N., Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "S."

Phrase: ","

Phrase: "Kawarabayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Scheff,"

Phrase: "S."

Phrase: ","

Phrase: "McGillis,"

Phrase: "J."
Processing 00000000.tx.312: P., Rydel, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rydel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.313: E., and Estus, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Estus,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.314: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.315: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.316: 20, 3937-3946[Abstract/Free FullText] Tucker, H. 

Phrase: "20,"

Phrase: "3937-3946"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tucker,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.317: M., Simpson, J., Kihiko-Ehmann, M., Younkin, L. 

Phrase: "M."

Phrase: ","

Phrase: "Simpson,"

Phrase: "J.,"

Phrase: "Kihiko-Ehmann,"

Phrase: "M."

Phrase: ","

Phrase: "Younkin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.318: H., McGillis, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "McGillis,"

Phrase: "J."
Processing 00000000.tx.319: P., Younkin, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.320: G., Degen, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Degen,"

Phrase: "J."
Processing 00000000.tx.321: L., and Estus, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Estus,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.322: (2004) Neurosci. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.323: Lett. 

Phrase: "Lett."
Processing 00000000.tx.324: 368, 285-289[CrossRef][Medline] [OrderarticleviaInfotrieve] Leissring, M. 

Phrase: "368,"

Phrase: "285-289"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Leissring,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.325: A., Farris, W., Chang, A. 

Phrase: "A.,"

Phrase: "Farris,"

Phrase: "W.,"

Phrase: "Chang,"

Phrase: "A."
Processing 00000000.tx.326: Y., Walsh, D. 

Phrase: "Y.,"

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.327: M., Wu, X., Sun, X., Frosch, M. 

Phrase: "M."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "X.,"

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X.,"

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.328: P., and Selkoe, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.329: J. 

Phrase: "J."
Processing 00000000.tx.330: (2003) Neuron 40, 1087-1093[CrossRef][Medline] [OrderarticleviaInfotrieve] Wei, L., Alhenc-Gelas, F., Corvol, P., and Clauser, E. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuron 40,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0027882:Neuron [Cell]
   861   C0439509:/40 [Temporal Concept]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1087-1093"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wei,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Alhenc-Gelas,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Corvol,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Clauser,"

Phrase: "E."
Processing 00000000.tx.331: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.332: Biol. 

Phrase: "Biol."
Processing 00000000.tx.333: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.334: 266, 9002-9008[Abstract/Free FullText] Beldent, V., Michaud, A., Wei, L., Chauvet, M. 

Phrase: "266,"

Phrase: "9002-9008"

Phrase: "[Abstract/Free FullText"

Phrase: "] Beldent,"

Phrase: "V.,"

Phrase: "Michaud,"

Phrase: "A.,"

Phrase: "Wei,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chauvet,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.335: T., and Corvol, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Corvol,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.336: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.337: Biol. 

Phrase: "Biol."
Processing 00000000.tx.338: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.339: 268, 26428-26434[Abstract/Free FullText] Balyasnikova, I. 

Phrase: "268,"

Phrase: "26428-26434"

Phrase: "[Abstract/Free FullText"

Phrase: "] Balyasnikova,"

Phrase: "I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]
Processing 00000000.tx.340: V., Karran, E. 

Phrase: "V., Karran,"

Phrase: "E."
Processing 00000000.tx.341: H., Albrecht, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Albrecht,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.342: F., II, and Danilov, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "II,"

Phrase: "and"

Phrase: "Danilov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.343: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.344: (2002) Biochem. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.345: J. 

Phrase: "J."
Processing 00000000.tx.346: 362, 585-595[CrossRef][Medline] [OrderarticleviaInfotrieve] Coates, D. 

Phrase: "362,"

Phrase: "585-595"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Coates,"

Phrase: "D."
Processing 00000000.tx.347: (2003) Int. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.348: J. 

Phrase: "J."
Processing 00000000.tx.349: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.350: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.351: 35, 769-773[CrossRef][Medline] [OrderarticleviaInfotrieve] Skidgel, R. 

Phrase: "35,"

Phrase: "769-773"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Skidgel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.352: A., and Erdos, E. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Erdos,"

Phrase: "E."
Processing 00000000.tx.353: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.354: (1987) Clin. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.355: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.356: Hypertens. 

Phrase: "Hypertens."
Processing 00000000.tx.357: A 9, 243-259[Medline] [OrderarticleviaInfotrieve] Michaud, A., Williams, T. 

Phrase: "A 9,"

Phrase: "243-259"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Michaud,"

Phrase: "A.,"

Phrase: "Williams,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.358: A., Chauvet, M. 

Phrase: "A.,"

Phrase: "Chauvet,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.359: T., and Corvol, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Corvol,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.360: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.361: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.362: 51, 1070-1076[Abstract/Free FullText] Wei, L., Clauser, E., Alhenc-Gelas, F., and Corvol, P. 

Phrase: "51,"

Phrase: "1070-1076"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wei,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Clauser,"

Phrase: "E.,"

Phrase: "Alhenc-Gelas,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Corvol,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.363: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.364: Biol. 

Phrase: "Biol."
Processing 00000000.tx.365: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.366: 267, 13398-13405[Abstract/Free FullText] Kohlstedt, K., Brandes, R. 

Phrase: "267,"

Phrase: "13398-13405"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kohlstedt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Brandes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.367: P., Muller-Esterl, W., Busse, R., and Fleming, I. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Muller-Esterl,"

Phrase: "W.,"

Phrase: "Busse,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Fleming,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331812:Fleming [Health Care Related Organization]

Phrase: "I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]
Processing 00000000.tx.368: (2004) Circ. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Circ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332520:Circ [Quantitative Concept]
  1000   C2347774:circ [Quantitative Concept]
Processing 00000000.tx.369: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.370: 94, 60-67[Abstract/Free FullText] Kehoe, P. 

Phrase: "94,"

Phrase: "60-67"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kehoe,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.371: G., Russ, C., McIlory, S., Williams, H., Holmans, P., Holmes, C., Liolitsa, D., Vahidassr, D., Powell, J., McGleenon, B., Liddell, M., Plomin, R., Dynan, K., Williams, N., Neal, J., Cairns, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Russ,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McIlory,"

Phrase: "S."

Phrase: ","

Phrase: "Williams,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Holmes,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Liolitsa,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Vahidassr,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Powell,"

Phrase: "J.,"

Phrase: "McGleenon,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Liddell,"

Phrase: "M."

Phrase: ","

Phrase: "Plomin,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dynan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Williams,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Neal,"

Phrase: "J.,"

Phrase: "Cairns,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.372: J., Wilcock, G., Passmore, P., Lovestone, S., Williams, J., and Owen, M. 

Phrase: "J.,"

Phrase: "Wilcock,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Passmore,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lovestone,"

Phrase: "S."

Phrase: ","

Phrase: "Williams,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Owen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.373: J. 

Phrase: "J."
Processing 00000000.tx.374: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.375: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.376: 21, 71-72[CrossRef][Medline] [OrderarticleviaInfotrieve] Elkins, J. 

Phrase: "21,"

Phrase: "71-72"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Elkins,"

Phrase: "J."
Processing 00000000.tx.377: S., Douglas, V. 

Phrase: "S."

Phrase: ","

Phrase: "Douglas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551777:Douglas [Population Group]

Phrase: "V."
Processing 00000000.tx.378: C., and Johnston, S. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Johnston,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.379: C. 

Phrase: "C."
Processing 00000000.tx.380: (2004) Neurology 62, 363-368[Abstract/Free FullText] Lehmann, D. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neurology 62,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "363-368"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lehmann,"

Phrase: "D."
Processing 00000000.tx.381: J., Cortina-Borja, M., Warden, D. 

Phrase: "J.,"

Phrase: "Cortina-Borja,"

Phrase: "M."

Phrase: ","

Phrase: "Warden,"

Phrase: "D."
Processing 00000000.tx.382: R., Smith, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.383: D., Sleegers, K., Prince, J. 

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Sleegers,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Prince,"

Phrase: "J."
Processing 00000000.tx.384: A., van Duijn, C. 

Phrase: "A.,"

Phrase: "van Duijn,"

Phrase: "C."
Processing 00000000.tx.385: M., and Kehoe, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kehoe,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.386: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.387: (2005) Am. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.388: J. 

Phrase: "J."
Processing 00000000.tx.389: Epidemiol. 

Phrase: "Epidemiol."
Processing 00000000.tx.390: 162, 305-317[Abstract/Free FullText] Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., and Soubrier, F. 

Phrase: "162,"

Phrase: "305-317"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rigat,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hubert,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Alhenc-Gelas,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cambien,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Corvol,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Soubrier,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.391: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.392: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.393: Invest. 

Phrase: "Invest."
Processing 00000000.tx.394: 86, 1343-1346[Medline] [OrderarticleviaInfotrieve] Kolsch, H., Jessen, F., Freymann, N., Kreis, M., Hentschel, F., Maier, W., and Heun, R. 

Phrase: "86,"

Phrase: "1343-1346"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kolsch,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jessen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Freymann,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kreis,"

Phrase: "M."

Phrase: ","

Phrase: "Hentschel,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Maier,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Heun,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.395: (2005) Neurosci. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.396: Lett. 

Phrase: "Lett."
Processing 00000000.tx.397: 377, 37-39[CrossRef][Medline] [OrderarticleviaInfotrieve] Sleegers, K., den Heijer, T., van Dijk, E. 

Phrase: "377,"

Phrase: "37-39"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sleegers,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "den Heijer,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "van Dijk,"

Phrase: "E."
Processing 00000000.tx.398: J., Hofman, A., Bertoli-Avella, A. 

Phrase: "J.,"

Phrase: "Hofman,"

Phrase: "A.,"

Phrase: "Bertoli-Avella,"

Phrase: "A."
Processing 00000000.tx.399: M., Koudstaal, P. 

Phrase: "M."

Phrase: ","

Phrase: "Koudstaal,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.400: J., Breteler, M. 

Phrase: "J.,"

Phrase: "Breteler,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.401: M., and van Duijn, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "van Duijn,"

Phrase: "C."
Processing 00000000.tx.402: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: (2005) Neurobiol. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.404: Aging 26, 1153-1159[CrossRef][Medline] [OrderarticleviaInfotrieve] Lendon, C. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "26,"

Phrase: "1153-1159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lendon,"

Phrase: "C."
Processing 00000000.tx.405: L., Thaker, U., Harris, J. 

Phrase: "L., Thaker,"

Phrase: "U.,"

Phrase: "Harris,"

Phrase: "J."
Processing 00000000.tx.406: M., McDonagh, A. 

Phrase: "M."

Phrase: ","

Phrase: "McDonagh,"

Phrase: "A."
Processing 00000000.tx.407: M., Lambert, J. 

Phrase: "M."

Phrase: ","

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.408: C., Chartier-Harlin, M. 

Phrase: "C., Chartier-Harlin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.409: C., Iwatsubo, T., Pickering-Brown, S. 

Phrase: "C., Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.410: M., and Mann, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mann,"

Phrase: "D."
Processing 00000000.tx.411: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.412: (2002) Neurosci. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.413: Lett. 

Phrase: "Lett."
Processing 00000000.tx.414: 328, 314-318[CrossRef][Medline] [OrderarticleviaInfotrieve] Katzov, H., Bennet, A. 

Phrase: "328,"

Phrase: "314-318"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Katzov,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bennet,"

Phrase: "A."
Processing 00000000.tx.415: M., Kehoe, P., Wiman, B., Gatz, M., Blennow, K., Lenhard, B., Pedersen, N. 

Phrase: "M."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wiman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gatz,"

Phrase: "M."

Phrase: ","

Phrase: "Blennow,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lenhard,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pedersen,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.416: L., de Faire, U., and Prince, J. 

Phrase: "L., de Faire,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Prince,"

Phrase: "J."
Processing 00000000.tx.417: A. 

Phrase: "A."
Processing 00000000.tx.418: (2004) Hum. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.419: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.420: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.421: 13, 2647-2657[Abstract/Free FullText] Savaskan, E., Hock, C., Olivieri, G., Bruttel, S., Rosenberg, C., Hulette, C., and Muller-Spahn, F. 

Phrase: "13,"

Phrase: "2647-2657"

Phrase: "[Abstract/Free FullText"

Phrase: "] Savaskan,"

Phrase: "E.,"

Phrase: "Hock,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003086:Hock [Body Location or Region]
  1000   C1522382:Hock [Body Location or Region]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Olivieri,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bruttel,"

Phrase: "S."

Phrase: ","

Phrase: "Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hulette,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Muller-Spahn,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.422: (2001) Neurobiol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.423: Aging 22, 541-546[CrossRef][Medline] [OrderarticleviaInfotrieve] Barnes, N. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "22,"

Phrase: "541-546"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Barnes,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.424: M., Cheng, C. 

Phrase: "M."

Phrase: ","

Phrase: "Cheng,"

Phrase: "C."
Processing 00000000.tx.425: H., Costall, B., Naylor, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Costall,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Naylor,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.426: J., Williams, T. 

Phrase: "J.,"

Phrase: "Williams,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.427: J., and Wischik, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Wischik,"

Phrase: "C."
Processing 00000000.tx.428: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.429: (1991) Eur. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.430: J. 

Phrase: "J."
Processing 00000000.tx.431: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.432: 200, 289-292[CrossRef][Medline] [OrderarticleviaInfotrieve] Arregui, A., Perry, E. 

Phrase: "200,"

Phrase: "289-292"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Arregui,"

Phrase: "A.,"

Phrase: "Perry,"

Phrase: "E."
Processing 00000000.tx.433: K., Rossor, M., and Tomlinson, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rossor,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Tomlinson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.434: E. 

Phrase: "E."
Processing 00000000.tx.435: (1982) J. 

Phrase: "(1982"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.436: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.437: 38, 1490-1492[Medline] [OrderarticleviaInfotrieve] Hu, J., Igarashi, A., Kamata, M., and Nakagawa, H. 

Phrase: "38,"

Phrase: "1490-1492"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hu,"

Phrase: "J.,"

Phrase: "Igarashi,"

Phrase: "A.,"

Phrase: "Kamata,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Nakagawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.438: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.439: Biol. 

Phrase: "Biol."
Processing 00000000.tx.440: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.441: 276, 47863-47868[Abstract/Free FullText] Leissring, M. 

Phrase: "276,"

Phrase: "47863-47868"

Phrase: "[Abstract/Free FullText"

Phrase: "] Leissring,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.442: A., Farris, W., Wu, X., Christodoulou, D. 

Phrase: "A.,"

Phrase: "Farris,"

Phrase: "W.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "X.,"

Phrase: "Christodoulou,"

Phrase: "D."
Processing 00000000.tx.443: C., Haigis, M. 

Phrase: "C., Haigis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.444: C., Guarente, L., and Selkoe, D. 

Phrase: "C., Guarente,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.445: J. 

Phrase: "J."
Processing 00000000.tx.446: (2004) Biochem. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.447: J. 

Phrase: "J."
Processing 00000000.tx.448: 383, 439-446[CrossRef][Medline] [OrderarticleviaInfotrieve] Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. 

Phrase: "383,"

Phrase: "439-446"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.449: Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.450: J. 

Phrase: "J."
Processing 00000000.tx.451: (1992) Nature 360, 672-674[CrossRef][Medline] [OrderarticleviaInfotrieve] Vekrellis, K., Ye, Z., Qiu, W. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 360,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "672-674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.452: Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. 

Phrase: "Q., Walsh,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Chesneau,"

Phrase: "V.,"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.453: R., and Selkoe, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.454: J. 

Phrase: "J."
Processing 00000000.tx.455: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.456: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.457: 20, 1657-1665[Abstract/Free FullText] Santos, R. 

Phrase: "20,"

Phrase: "1657-1665"

Phrase: "[Abstract/Free FullText"

Phrase: "] Santos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.458: A., Krieger, E. 

Phrase: "A.,"

Phrase: "Krieger,"

Phrase: "E."
Processing 00000000.tx.459: M., and Greene, L. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Greene,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.460: J. 

Phrase: "J."
Processing 00000000.tx.461: (1985) Hypertension 7, 244-252[Abstract/Free FullText] Johnson-Wood, K., Lee, M., Motter, R., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M., Tan, H., Games, D., Lieberburg, I., Schenk, D., Seubert, P., and McConlogue, L. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Hypertension 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: "244-252"

Phrase: "[Abstract/Free FullText"

Phrase: "] Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gordon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gordon,"

Phrase: "M."

Phrase: ","

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "Schenk,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "McConlogue,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.462: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.463: Natl. 

Phrase: "Natl."
Processing 00000000.tx.464: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.465: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.466: U. 

Phrase: "U."
Processing 00000000.tx.467: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.468: A. 

Phrase: "A."
Processing 00000000.tx.469: 94, 1550-1555[Abstract/Free FullText] Fuchs, S., Xiao, H. 

Phrase: "94,"

Phrase: "1550-1555"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fuchs,"

Phrase: "S."

Phrase: ","

Phrase: "Xiao,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.470: D., Cole, J. 

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Cole,"

Phrase: "J."
Processing 00000000.tx.471: M., Adams, J. 

Phrase: "M."

Phrase: ","

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.472: W., Frenzel, K., Michaud, A., Zhao, H., Keshelava, G., Capecchi, M. 

Phrase: "W., Frenzel,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Michaud,"

Phrase: "A.,"

Phrase: "Zhao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Keshelava,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Capecchi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.473: R., Corvol, P., and Bernstein, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Corvol,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Bernstein,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.474: E. 

Phrase: "E."
Processing 00000000.tx.475: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.476: Biol. 

Phrase: "Biol."
Processing 00000000.tx.477: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.478: 279, 15946-15953[Abstract/Free FullText] Hooper, N. 

Phrase: "279,"

Phrase: "15946-15953"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hooper,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.479: M., and Turner, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Turner,"

Phrase: "A."
Processing 00000000.tx.480: J. 

Phrase: "J."
Processing 00000000.tx.481: (1987) Biochem. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.482: J. 

Phrase: "J."
Processing 00000000.tx.483: 241, 625-633[Medline] [OrderarticleviaInfotrieve] Woodman, Z. 

Phrase: "241,"

Phrase: "625-633"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Woodman,"

Phrase: "Z."
Processing 00000000.tx.484: L., Oppong, S. 

Phrase: "L., Oppong,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.485: Y., Cook, S., Hooper, N. 

Phrase: "Y.,"

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "S."

Phrase: ","

Phrase: "Hooper,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.486: M., Schwager, S. 

Phrase: "M."

Phrase: ","

Phrase: "Schwager,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.487: L., Brandt, W. 

Phrase: "L., Brandt,"

Phrase: "W."
Processing 00000000.tx.488: F., Ehlers, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ehlers,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.489: R., and Sturrock, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sturrock,"

Phrase: "E."
Processing 00000000.tx.490: D. 

Phrase: "D."
Processing 00000000.tx.491: (2000) Biochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.492: J. 

Phrase: "J."
Processing 00000000.tx.493: 347, 711-718[CrossRef][Medline] [OrderarticleviaInfotrieve] Farris, W., Leissring, M. 

Phrase: "347,"

Phrase: "711-718"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Farris,"

Phrase: "W.,"

Phrase: "Leissring,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.494: A., Hemming, M. 

Phrase: "A.,"

Phrase: "Hemming,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0019080:HEM [Pathologic Function]
   966   C0280599:HEM [Therapeutic or Preventive Procedure]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.495: L., Chang, A. 

Phrase: "L., Chang,"

Phrase: "A."
Processing 00000000.tx.496: Y., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.497: J. 

Phrase: "J."
Processing 00000000.tx.498: (2005) Biochemistry 44, 6513-6525[CrossRef][Medline] [OrderarticleviaInfotrieve] Oba, R., Igarashi, A., Kamata, M., Nagata, K., Takano, S., and Nakagawa, H. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Biochemistry 44,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "6513-6525"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Oba,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882142:OBA [Organization]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Igarashi,"

Phrase: "A.,"

Phrase: "Kamata,"

Phrase: "M."

Phrase: ","

Phrase: "Nagata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takano,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Nakagawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.499: (2005) Eur. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.500: J. 

Phrase: "J."
Processing 00000000.tx.501: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.502: 21, 733-740[CrossRef][Medline] [OrderarticleviaInfotrieve] Binevski, P. 

Phrase: "21,"

Phrase: "733-740"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Binevski,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.503: V., Sizova, E. 

Phrase: "V., Sizova,"

Phrase: "E."
Processing 00000000.tx.504: A., Pozdnev, V. 

Phrase: "A.,"

Phrase: "Pozdnev,"

Phrase: "V."
Processing 00000000.tx.505: F., and Kost, O. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Kost,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.506: A. 

Phrase: "A."
Processing 00000000.tx.507: (2003) FEBS Lett. 

Phrase: "(2003"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.508: 550, 84-88[CrossRef][Medline] [OrderarticleviaInfotrieve] Kohlstedt, K., Busse, R., and Fleming, I. 

Phrase: "550,"

Phrase: "84-88"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kohlstedt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Busse,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Fleming,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331812:Fleming [Health Care Related Organization]

Phrase: "I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]
Processing 00000000.tx.509: (2005) Hypertension 45, 126-132[Abstract/Free FullText] Ohrui, T., Tomita, N., Sato-Nakagawa, T., Matsui, T., Maruyama, M., Niwa, K., Arai, H., and Sasaki, H. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Hypertension 45,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: "126-132"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ohrui,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tomita,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Sato-Nakagawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsui,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "M."

Phrase: ","

Phrase: "Niwa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Arai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Sasaki,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.510: (2004) Neurology 63, 1324-1325[Free FullText] Knopman, D. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neurology 63,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1324-1325"

Phrase: "[Free FullText"

Phrase: "] Knopman,"

Phrase: "D."
Processing 00000000.tx.511: (2004) Neurology 63, 1145[Free FullText] Birkenhager, W. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neurology 63,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1145"

Phrase: "[Free FullText"

Phrase: "] Birkenhager,"

Phrase: "W."
Processing 00000000.tx.512: H., Forette, F., and Staessen, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Forette,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Staessen,"

Phrase: "J."
Processing 00000000.tx.513: A. 

Phrase: "A."
Processing 00000000.tx.514: (2004) Curr. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.515: Opin. 

Phrase: "Opin."
Processing 00000000.tx.516: Nephrol. 

Phrase: "Nephrol."
Processing 00000000.tx.517: Hypertens. 

Phrase: "Hypertens."
Processing 00000000.tx.518: 13, 225-230[Medline] [OrderarticleviaInfotrieve] Cole, J., Quach du, L., Sundaram, K., Corvol, P., Capecchi, M. 

Phrase: "13,"

Phrase: "225-230"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cole,"

Phrase: "J.,"

Phrase: "Quach du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540681:DU [Idea or Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sundaram,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Corvol,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Capecchi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.519: R., and Bernstein, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Bernstein,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.520: E. 

Phrase: "E."
Processing 00000000.tx.521: (2002) Circ. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Circ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332520:Circ [Quantitative Concept]
  1000   C2347774:circ [Quantitative Concept]
Processing 00000000.tx.522: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.523: 90, 87-92[Abstract/Free FullText]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "87-92"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

